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ABSTRACT 
 
 
Effects of environmental growth conditions on the levels of 
sutherlandins 3 and 4 and sutherlandiosides B and D, in 
Sutherlandia frutescens (L.) R. Br. 
 
Darryn Whisgary 
M.Sc. Thesis South African Herbal Science and Medicine Institute, University of the 
Western Cape. 
 
Sutherlandia frutescens (L.) R. Br.  (Fabaceae), indigenous to the Western Cape 
region of South Africa, is found in a Mediterranean-type climate known for its many 
environmental stressors that can influence the levels of metabolites found in plants. 
Sutherlandia frutescens contains many known potential active constituents among 
them, flavonoids such as sutherlandins 3 and 4 (Su3 and Su4) and terpenoids such as 
sutherlandiosides B and D (SuB and SuD). Whether the profiles and levels of Su3, 
Su4, SuB and SuD are significantly affected by the environmental factors found in 
this area is however, unknown.  
 
iBatech
TM
 is an ethanolic plant extract that is  manufactured by researchers in the 
Department of Medical Biosciences, UWC, for use as a pesticide. HPLC analysis 
performed on Lycopersicon species treated with the iBatech
TM
 product have shown 
that it also caused an increase in the concentrations of total polyphenols in the plant 
(Klaasen et.al., unpublished data). Whether the treatment with iBatech
TM
 might also 
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cause an increase in the polyphenols such as sutherlandins 3 and 4 and 
sutherlandiosides B and D is also unknown.  
 
The objectives of this study were to determine the concentrations of sutherlandins 3 
and 4 (Su3 and Su4) and sutherlandiosides B and D (SuB and SuD) in S. frutescens 
collected from different sites and after the treatment with the iBatech
TM
 product. The 
specific objectives were: a) to locate and categorize sites where S. frutescens is 
grown, based on a selection of pertinent environmental growth factors, b) to 
determine and compare the concentrations of sutherlandins 3 and 4 and 
sutherlandiosides B and D in S. frutescens collected from the  different environmental 
growth sites and after treatment with the iBatech
TM
 product.  
 
To realize these objectives, S. frutescens samples were collected from eight different 
sites and broadly categorized into three environmental categories. A high-
performance liquid chromatography (HPLC) method using diode array ultraviolet 
detection (HPLC-DAD) for the simultaneous analysis of flavonoids and terpenoids 
was developed and validated, and used for the profiling and determination of the 
average levels of sutherlandins 3 and 4 and sutherlandiosides B and D in the samples 
from the sites and that treated with the iBatech
TM
 product.  
 
The Kruskal-Wallis test was used to determine statistically significant differences 
among the environmental categories. The post ANOVA, Dunn’s Multiple 
Comparison test was performed to determine which groups were significantly 
different. The Mann-Whitney, two-tail, t-test was used to compare each 
environmental category to the standard and the column statistics of the raw data was 
 
 
 
 
 V 
analyzed to determine significant differences among samples from the same 
environmental category. 
 
In the samples collected from the sites, the values represent the average levels of 
metabolites for each environmental category whereas the significance values 
indicated were among samples from the same environmental category. The levels for 
sutherlandin 3 were Afriplex
TM
 (Std.) 2495.08, the natural field (NF) 2810.33 
(P=0.0005), the cultivated field (CF) 2519.81 and the greenhouse (GH) 2580.25. The 
levels for sutherlandin 4 were significantly different when comparing the (NF) 
1495.67 (P=0.0001), (CF) 3114.42 (P=0.0140) and (GH) 2361.72 (P=0.0001), with 
the CF group showing the highest levels of Su4 and the NF showing the lowest. The 
levels for sutherlandioside B were (NF) 189.7 (P=0.0189), (CF) 594.56 (P=0.0140) 
and (GH) 326.72 (P=0.0001), however, the CF group showed the highest average 
levels for SuB. The levels for sutherlandioside D were (NF) 144.1 (P=0.0192), (CF) 
544.37 (P=0.0308) and (GH) 387.49 (P=0.0001), with the NF category having the 
lowest average levels.  
 
In the iBatech
TM
 treated samples, the values indicate the average levels of three 
samples in each treatment group. The levels for sutherlandin 3 were (control) 
9758.43, the (50%) 2232.63 and the (100%) 2031.97 treatment groups. The levels for 
sutherlandin 4) were (control) 2241.63, the (50%) 2247.47 and the (100%) 2392.60, 
with the 100% treatment group having the highest levels. The levels for 
sutherlandioside B were (control) 289.66, the (50%) 284.93 and the (100%) 332.30. 
The levels for sutherlandioside D were (control) 282.77, the (50%) 280.60 and the 
(100%) 315.13 treatment groups, with the 100% treatment group having the highest 
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levels. The levels of Su3, Su4, SuB and SuD were significantly different (P=0.0001) 
among all treatment groups. 
 
In conclusion, the data shows that only sutherlandin 4 (Su4) was significantly 
different when comparing the environmental groups. Due to the significant 
differences in the Su3, Su4, SuB and SuD levels among samples from the same group 
the levels of these metabolites cannot be correlated with the environmental groups.  
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CHAPTER 1 
Introduction 
 
 
Sutherlandia frutescens (L.) R. Br. (Fabaceae) synonymous with Lessertia frutescens, 
indigenous to the Western Cape region of South Africa, has been used extensively, by 
many cultures inhabiting this area. Sutherlandia has over 25 vernacular names but some 
of the most prominent are: “Cancer Bush”; “Kanker-Bos”; “Spear of the blood” and 
“Unwele”. The natural environment in which Sutherlandia is found is in the 
Mediterranean-type climate of South Africa. This climate has long warm summers and 
cool moist winters (Aschmann, 1973). Some of the environmental stresses experienced 
by Sutherlandia in its natural environment include: water-deficit stress, nutrient stress 
and salt stress, among others. In general such stressors affect the plant’s phenology and 
physiology, which in-turn affects the production/ synthesis of chemical constituents 
(secondary metabolites) in the plant. A previous study which tested whether water-deficit 
stress affected Sutherlandia’s physiology, indicated a decrease in carbon assimilation and 
nitrogen fixation, suggesting that the concentrations of secondary metabolites in this 
medicinal plant can indeed vary among the same species grown under different 
conditions (Whisgary et. al., unpublished data).    
 
Sutherlandia species contains many known constituents and as the plant is being more 
intensely investigated for therapeutic use new constituent molecules such as flavonoids 
and terpenoids are still being discovered. It is commonly known that Sutherlandia 
contains: free-amino acids such as asparagine, non-protein amino acids like canavanine, 
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pinitol, flavonoid glycosides and triterpenoid saponins, among others. The focus of this 
study is on the flavonoid glycosides and triterpenoid saponins found in Sutherlandia 
frutescens samples.  
 
Saponins are amphiphilic, non-volatile, surface-active triterpene glycosides that are found 
in a large number of Fabaceae species (Lasztity, et. al., 1998), and are bitter in taste 
(Price et. al., 1985). Triterpene saponins have attracted great interest due to their 
pharmacological properties, namely anti-HIV, anti-cancer, anti-tumor, anti-diabetic, anti-
inflammatory and hepatoprotective properties, among others (Dini et. al., 2008). 
Triterpenoid saponins were first detected in S. microphylla in (1969) by Brümmerhoff 
and isolated to a pure compound from S. frutescens by Gabrielse (1996). Moshe (1998) 
has reported a complex pattern of triterpene profiles in the various species, but limited 
variations in the same population. Fu et. al., (2008) recently discovered four new 
cycloartane glycosides respectively known as sutherlandiosides A, B, C and D. 
Cycloartane glycosides are believed to have immunostimulatory, anti-bacterial (Calis et. 
al., 1997), anti-tumor (Abdallah et. al., 1993), as well as chemopreventative effects (Tian 
et. al., 2005). Although Moshe (1998) has reported limited variations in triterpene 
profiles in the same population, it is however expected that the quantitative and 
qualitative compositions of these compounds in the plants, in addition to species 
variations, can also be affected by a number of environmental factors such as micro-
climate, season and plant development stage. Whether changes in environmental growth 
conditions affect the levels of sutherlandins 3 and 4 and sutherlandiosides B and D in S. 
frutescens is unknown.  
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Due to the multitude of factors that affect the chemical composition, and thus the potency 
of herbal medicines, the development and implementation of standardized herbal 
preparations are challenging. Whether the environmental growth conditions might affect 
the profile and level of the potential active constituents of S. frutescens, should enable 
one to produce better quality preparations of this widely used indigenous medicine. 
Various attempts have been made to increase the synthesis of secondary metabolites in 
plants (Bourgaud et. al., 2001).  
 
iBatech
TM
 is an ethanolic plant extract that is  manufactured by researchers in the 
Department of Medical Biosciences, UWC, for use as a pesticide to protect the plants 
from various pathogenic conditions. HPLC analysis performed on Lycopersicon species 
treated with the iBatech
TM
 product have shown that it also caused an increase in the 
concentrations of total polyphenols in the plant (Klaasen et.al., unpublished data). 
Whether treatment with iBatech
TM
 might also cause an increase in the polyphenols such 
flavonoid and cycloartane glycosides found in Sutherlandia is also unknown.  
 
This study was aimed at determining the effects of environmental conditions and 
treatment with iBatech
TM
 on the concentrations of sutherlandins 3 and 4 and 
sutherlandiosides B and D in S. frutescens plants. The specific objectives were:  
 
 to locate sites where S. frutescens is grown, broadly categorize the sites into 
environmental groups based on the pertinent environmental growth factors,  
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 to develop and validate a high-performance liquid chromatography – diode array 
detector method for Su3, Su4, SuB and SuD analysis,  
 
 to determine and compare the profiles and levels of Su3, Su4, SuB and SuD S. 
frutescens collected from the  different environmental growth sites and  
 
 to determine whether the application of the iBatechTM product increases the 
number and concentrations of secondary metabolites in S. frutescens. 
 
It was hypothesized that: 
 
 the profiles and concentrations of sutherlandins 3 and 4 and sutherlandiosides B 
and D in S. frutescens, collected from different sites, would vary and 
 
 the application of the iBatechTM product will increase the number and 
concentrations of sutherlandins 3 and 4  and sutherlandiosides B and D in S. 
frutescens.  
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CHAPTER 2 
Literature review 
 
The botany, classification of Sutherlandia, and its use in disease management, its primary 
and secondary metabolites, terpenoids and its use in disease management, the synthesis 
and chemistry of terpenoids, factors affecting metabolite synthesis, cycloartane 
glycosides and sutherlandiosides, scientific strategies to improve the synthesis of 
secondary metabolites, the environmental conditions in which S. frutescens is found, the 
intended uses of the iBatech
TM
 product and the use of high performance liquid 
chromatography for the assaying of terpenoids are reviewed and discussed here.  
 
2.1 Botany and classification of Sutherlandia 
Sutherlandia frutescens (L.) R. Br. (synonymous with Lessertia frutescens) is a perennial 
shrub, reaching a height of approximately two meters. It has a pinnately compound leaf 
structure with large bright-red flowers. The fruits are very distinctive and appear as 
inflated, bladdery/ papery pods (Phillips et. al., 1934). Sutherlandia is a pioneer plant, the 
first inhabitant plant in a new ecosystem, where no other plants seem to grow, and thus, 
can withstand harsh environmental conditions.  
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Figure 2.1: Freshly harvested Sutherlandia frutescens 
 With characteristic bright-orange flowers and papery seedpods. 
 
In classification, prominent geographical variations have been recorded within the genus 
Sutherlandia, with two species S. frutescens and S. tomentosa, comprising several 
regional forms (van Wyk et. al., 1997). Sutherlandia is also morphologically and 
chemically similar to the genera Lessertia, Astragalus and some other members of the 
Galegeae tribe but the genetic evidence to prove that it is in fact the same as Lessertia, is 
insufficient. A study conducted by van Wyk et. al., (1997) using enzyme electrophoresis 
concluded that even though there are genetic differences in Sutherlandia, it is however 
difficult to distinguish these differences.  
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2.2 The use of Sutherlandia in disease management 
Human immunodeficiency virus, acquired immune-deficiency syndrome (HIV/ AIDS), 
tuberculosis, diabetes mellitus, stress and cancers are all forms of diseases. They place a 
significant burden on the healthcare system and are becoming increasingly difficult to 
treat, cure and manage. All South Africans are either directly or indirectly affected by a 
number of infectious diseases. It is on a constant increase, due to factors such as; a poor 
economy; lack of education; lack of hope; lack of disease curative-effect and low patient 
drug compliance. Sutherlandia is used traditionally for the treatment of HIV/ AIDS, 
diabetes mellitus, tuberculosis, internal cancers, hypertension, as an anti-analgesic and 
anti-inflammatory.  
 
Many pharmaceutical Sutherlandia products/ formulations are available on the market 
(Hess et.al., unpublished data), namely, Phyto Nova Sutherlandia Su1
TM
 tablets and 
capsules, African Botanicals Sutherlandia tablets and gels, Big Tree Sutherlandia/ 
African Ginseng
TM
 tablets and capsules, Biogenesis Anti-aging Sutherlandia capsules, 
Terra Treatment Sutherlandia tablets, gels and capsules and Bioharmony Bio-
Sutherlandia tablets but unfortunately evidence supporting the use of Sutherlandia in 
disease management is lacking.   
 
Very little is known about how Sutherlandia shows efficacy in HIV/ AIDS patients. A 
clinical trial by Johnson et. al. (2007) concluded that diseased patients showed improved 
levels of energy and fitness, improved sleep patterns, an increase in appetite and a 
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significant increase in weight gain only among ill individuals. Other results report an 
increase in the count of CD4 cells and a decrease in the viral load in AIDS patients.  
 
A number of studies have been done to test the anti-oxidative, anti-inflammatory, anti-
analgesic and antibacterial effects of Sutherlandia. Anti-oxidative studies done by Tai et. 
al. (2004) and Fernandes et. al. (2004) showed the inhibition of the production of nitrous 
oxide (NO) by lipopolysaccharide-stimulated cells, and the aqueous extract of 
Sutherlandia captured a significant number of superoxide and hydrogen peroxide radicals 
and converted them to nontoxic molecules. Anti-inflammatory studies by Tai et. al. 
(2004), showed that the administration of Sutherlandia did not significantly inhibit the 
production of anti-inflammatory cytokines, i.e. TNF and IL-1, while Ojewole (2004) 
suggests that Sutherlandia administered during inflammation, has similar effects to that 
of the non-steroidal diclofenac, which inhibits prostaglandin and cyclooxygenases. 
Ojewole (2004) also showed that Sutherlandia significantly affected thermal and 
chemical pain in mice but these effects were dosage-dependant. An increase in dose 
resulted in an increase in the effect.  
 
Sutherlandia is believed to be an adaptogen. An adaptogen is any substance or chemical 
compound, which acts by regulating the body’s defences and plays an important role in 
homeostasis of the body’s metabolic functions (Brekhman et. al., 1969). It assists the 
body in defending itself against invading stressors and allows adaptation to sudden 
pressures more easily. Smith et. al. (2004) suggests a significant reduction in the stress 
levels of patients taking Sutherlandia. The administration of Sutherlandia has shown to 
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significantly reduce the percentage of corticosteroid (Smith et. al., 2004), with no effects 
on testosterone levels. This could be the main cause for mood enhancement and general 
improvement in health (Van Wyk et. al., 2004) in AIDS and cancer patients. The fact that 
testosterone was unaffected by Sutherlandia could also relate to the weight gain and 
general strength seen in these chronically ill patients as described by Johnson et. al. 
(2007).  
 
Sutherlandia frutescens “Cancer Bush” has been used traditionally for the treatment of all 
the above-mentioned disease states. Due to this, the Medical Research Council (SAMRC) 
of South Africa has declared this plant safe for use in clinical trials (Johnson et. al., 
2007), to assess and substantiate its use in the treatment of disease. Results obtained from 
clinical trials on Sutherlandia show an increase in CD4 T-cell count, believed to be due 
to the chemical L-canavanine, and an overall improvement in the quality of life in these 
patients due to the remaining actives. This knowledge has brought us to examine the 
means of increasing the active chemicals found in Sutherlandia, both primary and 
secondary, to improve Sutherlandia’s therapeutic ability. 
 
2.3 Primary and secondary metabolites found in Sutherlandia frutescens 
Intensive Sutherlandia research shows that the leaves contain a complex mixture of both 
primary and secondary metabolites namely the primary non-protein amino acids such as  
L-canavanine, L-arginine, pinitol, amino butyric acid (GABA), asparagines (Tai. et. al., 
2004)  and the secondary flavonoids and terpenoids such as sutherlandins 1,2,3 and 4 and 
sutherlandiosides A,B,C and D respectively (Fu et. al., 2008). Many of the primary 
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metabolites have already been studied and a fair knowledge of their possible 
pharmacological properties gained. The secondary metabolites have however not been 
investigated intensely enough, but is believed to have a wide range of pharmacological 
properties. 
 
L-canavanine is a non-protein amino acid and is derived from hydroxylamine. It is only 
present in plants from the Fabaceae family (Bell, 1958), and to date 60% of plants tested 
from this plant family have shown to contain canavanine. Sutherlandia was found to 
contain an average of 2.2 – 3 mg/g to dried plant material of canavanine. It is one of the 
most active ingredients found in Sutherlandia as it has many medicinal attributes 
(Swaffar, 1995 and Green, 1998) and is also an analogue to the amino acid L-argenine 
(van Wyk et. al., 2008). 
 
L-arginine is an alkaline amino acid and is another important constituent of Sutherlandia, 
found in concentrations of 3mg/g of dried plant material (Van Wyk et. al., unpublished 
data). L-arginine is involved in many fundamentality important bodily functions. It can 
be synthesized from many different proteins and is particularly rich in nitrogen 
concentrations. L-arginine acts as a precursor for nitrogen oxide (Andrew et.al., 1999), 
which is essential for blood vessels, circulation and for the transmission of neurons in the 
brain. It is also said that L-arginine improves the function of the heart as it improves 
pumping action and also ensures the formation of various hormones. It is involved in the 
release of growth hormones from the pituitary gland, insulin from the pancreas and 
noradrenalin from the adrenal glands. 
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L-arginine also plays a fundamental role in the immune system. It improves cellular 
immune response, contributes to T-lymphocyte formation, minimizes their malfunction 
and stimulates phagocytosis. It also promotes the healing (Stechmiller et.al., 2005 and 
Witte et.al., 2003) of wounds through its involvement in protein synthesis and assists the 
body in excretion of excess nitrogen during the ureic cycle, when the liver splits L-
arginine into urea and the amino acid ornithine.  
 
D-pinitol is a glycan present in Sutherlandia (Snyders, 1965), and many other plants of 
the Fabaceae family. In the body, D-pinitol is converted into D-chiro-inositol, and the 
latter is involved in a number of metabolic processes, namely blood sugar metabolism 
(Bates et. al, 2000), as its role as a second messenger. 
 
Gamma aminobutyric acid (GABA) is a by-product of the decarboxylization of glutamic 
acid. GABA and glycine are two of the most important neurotransmitter inhibitors in the 
central nervous system (van Wyk et. al., 2008). GABA acts by binding to specific 
receptors in the plasma membrane of both pre-synaptic and postsynaptic neurons. GABA 
binding to these receptors causes the opening of ion channels to allow either the flow of 
negatively-charged chloride ions into the cell or positively-charged potassium ions out of 
the cell. This results in a negative charge in the transmembrane potential, causing hyper-
polarization. GABA is modulated by numerous chemical substances which bind to 
different receptors, one of which affects the action of benzodiazepines, a group of 
substances with hypnotic, anxiolytic and anticonvulsive effects (Foster et.al., 2006 and 
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Chapouthier, et.al., 2001) thus Sutherlandia’s mood enhancement effects could also 
possibly be attributed to GABA (Sia, 2004). 
 
Asparagine, the acid amide of asparaginic acid, is a non-essential hydrophilic amino acid 
present throughout the body. Asparagines and glycine cause postprandial glucagons 
secretion while argentine and leucine stimulate release of insulin. Insulin is responsible 
for blood-sugar regulation and promotes the synthesis of muscle protein whereas 
glucagon activates gluconeogenesis from amino acids in the liver, resulting in an efficient 
reduction of amino acid concentration in plasma.  
 
Finally, the terpenes also known as isoprenes class of compounds, is one of the most 
diverse classes of metabolites. Buckingham (2004) lists over 30 000 forms in this class 
originating from both plants and animals. They have a diverse range of functions from 
flavours to fragrances, antibiotics, plant and animal hormones, membrane lipids, insect 
attractants and insect-deterrents, and also acts as mediators of the essential electron-
transport processes during plant photosynthesis and respiration. Terpenes form part of a 
number of bioactive natural plant products, from the phytol side-chain of chlorophylls 
and the diterpenoid skeleton, and make this a very important class of compounds in drug 
discovery and human health. The terpenes found in S. frutescens, specifically 
sutherlandiosides B and D, are the main focus of this study. 
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2.4 Terpenoids and its use in disease management 
Cycloartane glycosides are a form of triterpene glycoside. Reports suggest they have 
apoptotic activity due to cytotoxicity (Xiao et. al., 2005) and this could be invaluable in 
anti-cancer research. Manners et. al., (1999) developed a good understanding on the 
properties of terpenes and studies show that an increased amount of triterpenes are shown 
to have anti-malarial, anti-bacterial, anti-cancer, anti-HIV/AIDS (Kashiwada et. al., 
1998), anti-diabetic, anti-inflammatory (Banno et. al., 2004), hepatoprotective (Visen, 
1996) and anti-oxidant (Somova, 2003) among other properties. They also act on various 
stages of tumor development, including tumorigenesis inhibition (Lee et. al., 2001 and 
Folkman, 1995), tumor promotion (Liu, 1995) and induction of tumour cell 
differentiation (Lee et. al., 1994) with relatively high tumour cytotoxicity and low 
hepatotoxicity (Xiao et. al., 2005). Terpenoids also have a high bioavailability due to 
their abundance in our diets (Crowell, 1999 and Fraser et. al., 2004), which make these 
particularly attractive compounds for potential therapeutic agents. 
 
2.5 Terpenoids 
2.5.1Terpenoid synthesis 
Terpenoids are typically synthesized through 2 possible modes. The dimethylallyl 
pyrophosphate pathway (DMAPP), or biosynthesis of isopentenyl pyrophosphate 
pathway (IPP). The dimethylallyl pyrophosphate (DMAPP) and isopentenyl 
pysosphosphate (IPP) are the universal 5-carbon precursor molecules (Ainsworth, 2006) 
which combine to form the basic terpene structure. In green plants (Shah et. al., 1969), 
algae (Schwender et. al., 1996) and some bacteria (Pandian et. al., 1981) an alternative 
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pathway namely the 1-deoxyxylulose phosphate (1-DXP) pathway, has been discovered. 
This pathway synthesizes terpenes in the plastids of green tissues and oil gland cells.  
 
The 1-DXP pathway, operating in plasmids, is responsible for the formation of essential 
oil monoterpenes (Eisenreich et. al., 1997), some sesquiterpenes (Adam et. al., 1999), 
diterpenes (Eisenreich, 1996) and carotenoids and phytol (Lichtenthaler et. al., 1997). 
The mevalonate pathway is responsible for the synthesis of triterpenes, sterols and most 
sesquiterpenes (Lichenthaler, 1999). A study in lima bean by Piel et. al., (1998) suggests 
that a limited degree of “cross-talk” occurs whereby the two pathways cross during the 
production of terpenes. This “cross-talk” is believed to be advantageous to the plant 
during nutrient stress.    
 
2.5.2 Factors affecting terpenoid synthesis 
Generally, secondary metabolites are thought to be synthesized during adverse 
environmental conditions (Passam et. al., 2007) as a protective measure taken by the 
plant, whereas other reports suggest the exact opposite. The argument being, that during 
adverse environmental conditions, essential soil nutrients often become unavailable to the 
plant. Often the syntheses of secondary metabolites rely on the availability of nutrients 
such as carbon and nitrogen molecules and if they are unavailable during adverse 
environmental conditions, how then can secondary metabolites be synthesized? A study 
conducted by Mosaleeyanon et. al. (2005) concluded that secondary metabolite 
concentrations were dramatically higher in plants grown in a controlled environment 
compared to the same plant species grown in the field. This could be as a result of 
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photosynthesis-limiting factors such as temperatures that exceed the optimum for plant 
growth or wind, which reduces the relative humidity.  
 
Secondary metabolite synthesis depends mainly on the physiological metabolism of many 
of the macronutrients, namely carbon and nitrogen. A previous study by Whisgary et. al. 
(unpublished data), indicated by, the rate of photosynthesis, the rate of transpiration, 
stomatal conductance as well as the assimilation of carbon and nitrogen, that water-deficit 
stress affects the physiology of Sutherlandia frutescens seedlings, possibly due to the 
unavailability of carbon and nitrogen. When macronutrients such as these become 
unavailable, the plant’s physiology and metabolism is compromised, and could therefore 
affect the synthesis of secondary metabolites. A study by Haefele et. al. (2008) suggests 
that the efficiency and use of supplementary nitrogen is not affected by water-deficit 
stress, but depends greatly on species and cultivar. On the contrary, a study by Ercoli et. 
al., (2007) suggests that the accumulation and remobilization of nitrogen is adversely 
affected during water-deficit stress and thereby affects plant biomass. Carbon molecules 
are one of the major components of the terpenoid structure and when carbon 
accumulation and assimilation is compromised it could have an effect on terpenoid 
synthesis. Bourgaud et. al., (2001) explains that during the earlier growth stages the 
carbon assimilated is allocated to primary metabolism (the production of cell structures) 
and later when plant growth plateaus, carbon will no longer be required in large quantities 
and secondary compounds can be more actively synthesized.  
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2.6 Terpenoid chemistry 
Terpenes are very widely spread in nature and occur in many plant and animal species 
including humans (Crozier et. al., 2006), with a chemical structure based on multiples of 
C5 units, and are often attached to a glycoside. Terpenes contribute to many of the 
aromatic properties of plants and range structurally from simpler to more complex 
molecules from C5 units to C30 units (Ainsworth, 2006). Their structural complexity 
determines the chemical molecule they form e.g. latex, rubber and leaf waxes. They come 
from a class of compounds that are highly structurally diverse from one another and have 
extensive functional group chemistry. The simplest terpenes are called hemiterpenes (C5) 
and are produced by modification reactions to either dimethylallyl pyrophosphate 
(DMAPP) or isopentenyl pysosphosphate (IPP) and include simple acids (isomers) such 
as tiglic acid and angelic acid, which form esters with many natural products. 
Monoterpenes (C10), sesquiterpenes (C15), diterpenes (C20), triterpenes and steroids (C30) 
and tetraterpenes (carotenoids, C40) are all medicinally important.   
 
Triterpenes (C30-derived terpenoids) has exceptionally wide distribution in humans, 
plants, fungi, bacteria, soft corals and amphibians. They include very important 
molecules such as steroids (Dharmananda, 2000), e.g. testosterone/ oestrogen, which are 
degraded triterpenes with fundamental importance in mammals, such as pheromones. 
Triterpenes are also components of resins and resinous exudates from plants and are often 
bitter in taste, a characteristic displayed by many triterpenes. They are usually produced 
as a physical barrier in injured plants, to prevent microbial attack on plants and therefore 
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exhibit anti-bacterial and anti-fungal activity by either killing off invading microbes or 
down-regulating microbial growth, allowing the plant to heal itself (Crozier et. al., 2006).  
 
2.7 Cycloartane glycosides and sutherlandiosides 
Glycoside is the collective name given to molecules that attach themselves to other 
molecules making them more structurally complex. The term “glycoside” is a generic 
term for a natural product that is chemically bound to a sugar. Thus, glycosides are made-
up of two parts: (i) the aglycone and (ii) sugar (Dharmananda, 2000). The sugar can be 
bound to any type of molecule namely: flavonoids, terpenoids and coumarins among 
others. thus making the compound more hydrophilic. Glycosides come from one of two 
classes; C-glycosides or O-glycosides differing only by the type of bonds. C-glycosides 
have carbon-carbon bonding whereas O-glycosides have oxygen-carbon bonding types.  
 
 
Figure 2.2: The basic chemical structure of a triterpene glycoside (Dharmananda, 
2000) 
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Triterpene glycosides have a widespread distribution throughout the plant kingdom and 
are commonly/ collectively referred to as saponins due to their ability to form foams in 
solution. Triterpene glycosides have steroid-like structures and can have similar effects as 
steroids during overuse such as: hypertension and thrombosis.  
 
 
Figure 2.3: The basic chemical structure of a cycloartane glycoside (Gaube et.al. 
2007) 
  
Brümmerhoff (1969) first detected triterpene glycosides in Sutherlandia microphylla 
leaves but the chemical structures were not elucidated. Gabrielse (1996) isolated and 
purified the first reported triterpene glycoside from S. microphylla and this was later 
called sutherlandioside 1 (SU1). Moshe (1998) found that various Sutherlandia species 
contained complex patterns on triterpenes with limited variations with the same 
population but much larger variations between populations. Albrecht (unpublished data) 
also reported that cycloartane-type glycosides vary dramatically among geographic 
regions in South Africa and to date; at least 56 triterpene glycosides have been reported in 
Sutherlandia. The major triterpene in commercial Sutherlandia material is SU1 and has 
been structurally elucidated (Figure 2.4) by Fu et. al., (2008) and Olivier et. al., (2009).  
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Figure 2.4: Structural elucidations of sutherlandiosides by Fu et. al. (2008) 
 
2.8 Strategies to improve secondary metabolite synthesis  
Over the last 50 years, various strategies have been extensively investigated to improve 
the production of secondary metabolites. Plant cell culture technology, plant physiology, 
plant anatomy, DNA sequencing and gene selection being a few of the prominent 
approaches explored. Despite great technological advances, biotechnological approaches 
to this have proven to be costly with few commercial successes (Bourgaud et. al., 2001).  
Some researchers believe that plants grown in the natural field, exposed to abiotic and 
biotic factors can adversely affect the safety of these medicinal plants and could be 
harmful to consumers (Southwell et. al., 2001). Others such as Zobayed et. al., (2004), 
report high secondary metabolite yields from medicinal plants grown in a controlled 
environment with high levels of CO2 and light irradiation. However, with studies like 
these it is not totally clear whether the increase in secondary metabolites are due to the 
freely available CO2 and light which maximizes photosynthesis or whether the plant is 
reacting to CO2 and light radiation stress.  
A study by Chinkwo (2005) to determine the effectiveness of Sutherlandia against cancer 
confirmed that Sutherlandia extracts has apoptotic inducing properties when tested 
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against Chinese hamster ovary (CHO), Caski and Jurkat T-lymphoma cell lines but are 
population, dose and location dependant. Tai et. al., (2004) in a study using Sutherlandia 
ethanolic extract against human tumour cell lines showed anti-tumor properties but these 
results were dosage dependant and samples obtained from the Western Province area 
showed greater apoptotic inducing capabilities compared to samples from the Northern 
Province and Orange Free State. These observations suggest that the location where 
Sutherlandia is grown could affect the chemical composition, due to factors such as soil 
composition, percentage of annual rainfall and UV light intensity, which also leads to the 
synthesis of secondary metabolites (Wink, 1999). These factors can therefore either 
promote or compromise the synthesis of secondary metabolites. 
 
2.9 Growth environments in which Sutherlandia is found 
The Cape floristic region of South Africa is classified as a Mediterranean-type climate. 
This climate is comprised of long dry summers and cooler moist winters, with up to 60% 
of the annual rainfall occurring during the winter months (Aschmann, 1973). These 
Mediterranean-type biogeographical regions comprise of some of the most diverse flora 
in the world (Cowling et. al., 1996) and are particularly threatened by global climate 
change (McCarthy et. al., 2001 and Lovette et. al., 2005). The evergreen shrubs occurring 
in the Mediterranean-type climate of South Africa is collectively known as Fynbos. 
Structurally, they are generally smaller shrubs growing between 20 cm – 1.5 m in height 
with hairy leaves. With the predictable summer dry period (Cowling et. al., 2005), this 
flora needs to be able to cope with negative xylem pressures while still transporting water 
to the leaves and actively expanding shoots (Agenbag, 2006). Mediterranean-type 
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climates contain from seasonal dimorphics to evergreen schlerophylls. These differ both 
physiologically as well as structurally in their ability to cope with adverse environmental 
conditions such as stress (Mooney et. al., 1970 and Werner et. al., 1999). Plants grown in 
warm climates such as these may be water stressed especially during late spring and 
summer (Haefele et. al., 2008). The availability of water is generally an important factor 
essential for plant growth; however, it can often exceed threshold values before affecting 
phenology. Phenological development is only really affected under severe drought stress 
levels (Rassaa et. al., 2008).  
 
In severe stress conditions, plants synthesize various chemical compounds (Passam et. 
al., 2007) to cope with stresses. Some of these stresses for which plants synthesize 
chemicals could be: pest; drought; saline soils; nutrient starvation; UV light intensity or 
any other adverse environmental conditions. Examples of such chemicals found in 
Sutherlandia are the primary metabolites L-canavanine, L-argenine, pinitol, GABA and 
asparagines and the secondary metabolites like flavonoids and terpenoids among others. 
This has lead us to examine the various environments in which Sutherlandia is grown and 
determine which environment is best suited for the production of metabolite-rich 
medicinal Sutherlandia plants.   
 
2.9.1 Natural field conditions      
There is no control over temperature, humidity, wind or light intensity, water regimes and 
any supplementary fertilization or pest control management. The survival of these plants 
are solely subjective to the micro-climatic conditions under which they are found and are 
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usually well adapted to suit those specific environmental conditions, often due to natural 
selection and survival of the strongest genes (Simões et. al., 2007). These plants are often 
more acclimatized to harsher environmental conditions than plants grown in greenhouses 
or shade houses but are still at risk if one of the environmental conditions is drastically 
altered. If so, an entire plant population can be destroyed.  
 
2.9.2 Cultivated field conditions 
Usually water regime and supplementary fertilization or pest control is practiced but due 
to the open-air environment, wind, light intensity and humidity cannot be controlled. The 
major advantage of field cultivation is relatively low management costs when compared 
to the greenhouse but the disadvantage with field cultivation is that atmospheric 
temperatures cannot be maintained. The plants therefore need to withstand high midday 
temperatures and often drastically cooler night-time temperatures, during the summer 
months. During winter, plants often have to withstand temperatures below zero degrees 
Celsius while still maintaining an active metabolism. Plants cultivated in fields such as 
these are mostly species specific and depends greatly on the climatic conditions of the 
region.  
 
2.9.3 Greenhouse conditions                       
Plants are grown in greenhouses for various reasons. One of the main reasons are to 
control the environmental conditions, namely irrigation, humidity, temperature and light 
intensity. Greenhouses are typically divided into two major sections, the glasshouse 
section, where seedlings and environmentally-sensitive plants are grown, and the shade-
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house section, where the plants are placed to acclimatize before being introduced to the 
outside environment (Janick, 1963). The shade-house section is also used as a storage 
facility for plants waiting to be sold or moved out into the field. A shade-house is 
typically made of landscape shade netting and allows you to control wind and light 
intensity, water regime when coupled with an irrigation system and the use of 
supplementary fertilization and pest control. The three major shade net colours used for 
this purpose are black, green and white and inhibit 70%, 60% and 40% of light 
respectively. The major disadvantages of shade-houses are that neither humidity nor 
temperature can be controlled.  
 
2.10 iBatech
TM
 product 
Klaasen et. al. (2009) patented a plant derived extract, which is used as an adjuvant. It is 
an ethanolic extract (patent ref. no. PA149863/P) of an indigenous South African plant 
and is believed to promote the synthesis of secondary plant metabolites. Some testing has 
been done using this product as an adjuvant spray application on agricultural crops 
resulting in an increase in total polyphenolics (Klaasen et. al., unpublished data) when 
analyzed using HPLC. No literature has as yet been published on the iBatech
TM 
product 
and no studies have been done on its possible mechanisms of action to date.  
 
2.11 Techniques used to assay for terpenoids 
There is a great need for standardizing commercial plant products by conducting quality 
control studies. Various assays have been reported, based on a wide variety of analytical 
techniques, including high performance liquid chromatography (HPLC), or capillary 
 
 
 
 
  
24 
electrophoresis with ultraviolet (UV) absorbance detection, HPLC with refractive index 
(RI) detection, HPLC with evaporative light scattering detection (ELSD), gas 
chromatography (GC) with flame ionization detection (FID), GC-mass spectrometry 
(GC-MS), nuclear magnetic resonance (NMR), and liquid chromatography-mass 
spectrometry (LC-MS) (van Breemen et. al., 2007). These means of assay have a 
considerable amount of advantages but also have limitations. It is thus important to 
understand the chemistry of the compound of interest to select the best-suited method for 
analysis.  
 
Refractive index detection lacks both sensitivity and selectivity and is more suitable for 
monitoring preparative HPLC separations than for quantitative analysis. Evaporative light 
scattering detection responds to both terpenoids and flavonoids, although the standard 
curves are non-linear. However, like UV and refractive index detection, ELSD lacks 
selectivity. Although both GC with flame ionization detection and GC-MS are highly 
sensitive analytical techniques, GC-based methods require complicated and time-
consuming sample preparation and derivatization. NMR-based assays often lack 
sensitivity and are slow compared to LC-MS assays (van Breemen et. al., 2007).  
 
HPLC assaying facilitates the rapid quantitative analysis of various plant and dietary 
supplements with excellent recovery, reproducibility, accuracy, and sensitivity, and does 
not require sample derivatization prior to analysis, however, there are limitations. Plant 
extracts usually contain considerable quantities of flavonoids, which have strong UV 
absorption and terpenoids, which lack UV chromophores thus making detection using 
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UV difficult. Even trace amounts of co-eluting compounds such as the abundant 
flavonoids can interfere with the detection of terpenoids. Therefore assays based on UV 
absorption lack sensitivity and selectivity for the quantitative analysis of terpenoids in 
complex plant extracts. However this can be overcome by the development of a suitable 
HPLC method, developed specifically for the analysis of the compound of interest like 
the method developed by Avula et. al., (2010) for the analysis of sutherlandiosides B and 
D. Reversed-phase HPLC coupled with photodiode array detection has become one of the 
most widely used techniques for the identiﬁcation, and quantiﬁcation of plant compounds 
and allows individual compounds to be separated by their polarity, which cause them to 
elute at different times and can be quantified with the use of an external standard. HPLC 
is therefore a suitable technique to determine with reasonable accuracy the presence and 
concentrations of secondary metabolites in Sutherlandia frutescens grown under varying 
environmental conditions.  
 
2.12 Summary 
A review of the available literature on the botany, uses and metabolite synthesis of 
Sutherlandia frutescens shows that this plant has been fairly well investigated. The fact 
that it is used as a phytotherapeutic requires the plant to meet strict drug compliance 
regulations as set out by the Medicines Control Council of South Africa (MCC). 
Although studies are being carried out on S. frutescens to investigate the medicine 
production-stage requirements of the MCC, little research is focussed on the effects that 
the plant growth-stage have on the final Sutherlandia medicinal product. Numerous 
studies suggest that primary and secondary metabolite synthesis in plants can be 
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significantly affected by environmental conditions. To our knowledge no work has as yet 
been done to determine the effects of environmental growth conditions on the synthesis 
of sutherlandins 3 and 4 and sutherlandiosides B and D in S. frutescens.  
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CHAPTER 3 
 
Aim, objectives, hypothesis and approach 
 
3.1 Aim, objectives, hypothesis and approach 
3.1.1 The aim of the study 
This study was aimed at determining the effects of environmental conditions, on the 
levels of sutherlandins 3 and 4 and sutherlandiosides B and D in S. frutescens.  
 
3.1.2 The objectives of the study 
The specific objectives were:  
 to locate sites where S. frutescens is grown, broadly categorize the sites into 
environmental groups based on the pertinent environmental growth factors,  
 
 to develop and validate a high-performance liquid chromatography – diode array 
detector method for Su3, Su4, SuB and SuD analysis,  
 
 to determine and compare the profiles and levels of Su3, Su4, SuB and SuD S. 
frutescens collected from the  different environmental growth sites and  
 
 to determine whether the application of the iBatechTM product increases the 
number and concentrations of secondary metabolites in S. frutescens. 
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3.1.3 Hypothesis 
It was hypothesized that:  
 S. frutescens grown in the natural field and cultivated field groups will have an 
increase in the number and concentrations of sutherlandins 3 and 4 and 
sutherlandiosides B and D compared to that of the greenhouse group. 
 The application of the iBatechTM product will increase the concentrations of 
sutherlandins 3 and 4 and sutherlandiosides B and D. 
 
3.2 The study approach   
To realize the above-mentioned objectives, the following was done. 
 
3.2.1 Identification of sites where S. frutescens is grown and the pertinent growth 
factors  
Various sites where S. frutescens is grown where visited and broadly categorized into 
environmental categories, based on the pertinent environmental growth factors. The 
weather conditions at the time of harvest, the factors that we assumed could limit the 
synthesis of secondary metabolites, and plant heights were documented. This 
environmental growth factor identification was done to be able to correlate the 
environmental categories with the concentrations of sutherlandins 3 and 4 and 
sutherlandiosides B and D.  
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3.2.2 Determination of sutherlandins 3 and 4 and sutherlandiosides B and D profiles 
and concentrations in S. frutescens plants from different growth sites. 
To determine the sutherlandins 3 and 4 and sutherlandiosides B and D profiles and 
concentrations HPLC was used. It is appropriate, accurate and precise and has the ability 
to provide scientifically acceptable results. It is sensitive, to easily detect compounds and 
allows for the simultaneous analysis of flavonoids and terpenoids. A new method will be 
developed based on a method developed by Avula et. al., (2010) and will be validated 
according to the guidelines as set out by the International Conference for Harmonization 
(ICH), to assay for sutherlandins 3 and 4 and sutherlandiosides B and D using HPLC  - 
DAD. This new HPLC method will be used to determine the profiles and average levels 
of sutherlandins 3 and 4 and sutherlandiosides B and D of S. frutescens collected from the 
different sites, and that treated with the iBatech
TM
 product. The Sutherlandia frutescens 
Afriplex
TM
 sample was used as the standard plant material.  
 
3.2.3 Determination of the effects of iBatech
TM
 treatment on the profiles of 
sutherlandins 3 and 4 and sutherlandiosides B and D 
According to the manufacturers, the iBatech
TM
 product, in previous studies has shown to 
increase overall polyphenol count in Lycopersicon agricultural crops. In these studies, 
general polyphenols were assayed for but specific classes of compounds were not. Only 
one HPLC assay was run on samples treated with the iBatech
TM
 product and thus, a 
thorough understanding of the chemical changes taking place in these plant samples are 
not fully understood. The use of HPLC-DAD would provide a better understanding of the 
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type of chemical changes taking place in the plants when treated with the iBatech
TM
 
product at varying concentrations.  
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CHAPTER 4 
Methods 
  
This chapter describes the chemicals, materials, equipment and methods used. The 
identification of the sites where Sutherlandia is grown, with their relative pertinent 
growth factors, are documented, the collection, preparation and storage of plant material 
are described. The iBatech
TM
 treatment experiment, the development and validation of an 
HPLC assay for the identification and profiling of sutherlandins 3 and 4 and 
sutherlandiosides B and D and the concentrations of the latter of S. frutescens from the 
varying environmental growth categories are presented here.  
 
4.1 Chemicals, products and equipment 
4.1.1 Chemicals and products 
The methanol used for extractions and acetonitrile (HPLC grade) used for HPLC assays 
were purchased from Merck chemicals, SA. The distilled water also used for the HPLC 
assays was prepared in the pharmacology laboratory and purified using a (Glass Chem 
WS8Lc, Waterstill 8 L/H, 220 V). The plant material was collected from the wild, 
donated by Kirstenbosch botanical gardens, the University of the Western Cape 
greenhouse and local farmlands from the Western Cape area growing S. frutescens for 
medicinal use. The patent holder, Dr. J. Klaasen Department of Medical BioSciences, 
University of the Western Cape, provided the iBatech
TM
 product used in this experiment 
(Patent reference number PA149863/P, batch number IF/UWC – T70023). The 
sutherlandiosides B and D ratio used as the standard, to construct the calibration curves, 
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were obtained from the University of Mississippi. The consumables used were; test tubes 
(Cellstar 15 ml, PP, graduated, sterile, blue cap), airtight plastic bags (Packit 1 BRC 
2536, SA), millipore filters (Millipore Millex-HV, hydrophilic PVDF 0.45 um), syringes 
(K 12 5ml) and amber HPLC vials (Supelco, conv pack 8/425, PTFE/ Silicone/PTFE 
Septa, USA).  
 
4.1.2 Equipment 
A ventilated oven (Memmert, 854 Schwabach, Western Germany), a coffee grinder 
(Philips Cucina coffee grinder Type HR 1737, Brazil), a weighing balance (AR 2140 Max 
cap. 210 g, China), a vortex (Vortex Genie 2, model no. G-560E, Scientific industries, 
USA), a centrifuge (Labofuge 200 Heraeus Sepatech 1,2 kg/dm
3
 Germany) and a pipette 
(Finnpipette 773676 thermo Electronic 100-1000 ul) were used in this experiment.   
 
4.2 Location of the sites in which S. frutescens is grown in the Western Cape area, 
collection, preparation and storage of plant material  
Sites in the Western Cape area where S. frutescens are grown were visited during a thirty-
day period from September to October 2009 during early spring. Eventually eight S. 
frutescens sites were identified and broadly categorized into natural field, cultivated field 
and greenhouse based on the location and the conditions under which the plants were 
growing. For each site the pertinent environmental growth factors, which we assume may 
affect the synthesis of secondary metabolites were identified and documented.  
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To determine the effects of the growth factors collectively on sutherlandins 3 and 4 and 
sutherlandiosides B and D in S. frutescens, plant samples were collected in the following 
order. The natural field and cultivated field categories plant samples were collected from 
three sites each, while for the greenhouse category, which is not common practise for the 
growth of S. frutescens, samples were only collected from two sites. Thus, plant samples 
from eight Sutherlandia sites were collected for this study. From each of the eight, 
selected Sutherlandia sites, a minimum of three samples of leaf and stem material per site 
were collected. All samples were oven-dried at 40 ˚C for 72 hours after collection and 
thereafter the flowers and seedpods removed. The leaves and stems were then ground into 
a powder and put into appropriately labelled airtight plastic bags. In order to prevent 
moisture, light and oxidative stress from compromising the quality of the S. frutescens 
powdered material; the bags were placed inside a brown cardboard box and placed inside 
a cool, dry cupboard for storage until analysis.  
 
In preparation for HPLC analysis, the three samples from each site were weighed 
individually to obtain 1 g per sample, these were then combined, shaken, and 1 g of this 
homogenized material taken as a representative sample for the site. In addition, one 
further sample from each site was collected and used by a botanist, for species 
verification. At the time of sampling, the size of the plant, the weather conditions, the 
presence of flowers and/ or seedpods were also determined and recorded.  
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         (a) (b)  
 
 
Figures 4.1: The collection of plant samples from (a) the natural field, (b) cultivated field and (c) greenhouse environmental 
categories 
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 (c)                                           
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4.3 Determination of profiles and peak areas of sutherlandins 3 and 4 and 
sutherlandiosides B and D in S. frutescens plants from different growth sites  
To identify and quantify the sutherlandins 3 and 4 and sutherlandiosides B and D, an 
HPLC method was developed according to a method adapted and modified from the 
method developed by Avula et. al., (2010). The method was validated according to the 
International Conference on Harmonization (ICH) guidelines on the validation of 
analytical methods (Baber, 1994 and ICH, 1996). Triplicate analyses were conducted on 
three Sutherlandia frutescens samples purchased from Afriplex
TM
 (Paarl 7620, South 
Africa) for use as the standard plant material. Calibration curves were constructed by 
preparing serial dilutions of the standard SuB/ SuD compound ratio and the peak area 
values and the best-fit method was used to determine linearity. Inter and intra-day 
samples were prepared as all other plant samples previously described. Intra-day assay 
accuracy was determined from three S. frutescens Afriplex
TM
 samples analyzed in 
triplicate, whereas inter-day accuracy involved the calculation of the mean values of three 
samples analyzed in triplicate and also quantified in terms of percentage RSD over three 
different days.  
 
4.3.1 HPLC system 
An Agilent 1200 series HPLC system was used. It consisted of a degassing system 
(G1322A, Japan), a quaternary pump (G1311A, Germany), a auto sampler (G1329A, 
Germany), a C18 Discovery
TM
 column 150mm x 4.60mm, 5um (Discovery, BL6357 HS, 
USA), coupled with a diode-array detector (G164C, Germany), a fluorescence detector 
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(G1521A, Germany) and a fraction collector (G164C, Germany), managed by the Agilent 
Chemstation software.    
 
4.3.2 HPLC conditions  
The plant samples were analyzed for sutherlandins 3 and 4 and sutherlandiosides B and 
D, according to a method adapted and modified from a method developed by Avula et. 
al., (2010). Ten micro litre (10 µL) samples were injected onto the HPLC C18 
Discovery
TM
 column, maintained at 25 ˚C, and the compounds eluted using the following 
solvent system and gradient: of acetonitrile (A) and distilled water (B) both with 0.1 % 
formic acid; and gradient: A:B (20:80) at time 0; A:B (60: 40)  at 20 minutes; A:B 
(60:40)  from time 20 – 25 minutes; A:B (100:0) from 25 – 30 minutes and A:B (80:20) 
from 30.1 – 40 minutes, with a flow rate of 1.000 ml / minute. The compounds in the 
eluent were detected by UV at 254 nm, with the use of a diode-array detector and the SuB 
and SuD fractions collected for liquid chromatography – mass spectrometric (LC-MS) 
analysis, based on the retention times and threshold values.  
 
4.3.3 Preparation of plant samples for HPLC analysis  
The samples of plants collected from the various sites and those included in the 
iBatech
TM
 product experiment, were analyzed for the presence, or absence, of 
sutherlandins 3 and 4 and sutherlandiosides B and D, using HPLC. One gram of each 
representative sample was placed into a test tube and combined with 10 ml of methanol, 
vortexed for 2 minutes, placed into a sonicating bath at room temperature for 20 minutes, 
vortexed for a further two minutes, then centrifuged at 3500 rpm for 10 minutes. The 
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supernatant was removed, filtered through a millipore filter using a syringe and placed 
into an amber HPLC vial for analysis. Ten micro litres (10 µL) were injected onto the 
HPLC column and the fingerprints obtained were used to compare sutherlandins 3 and 4 
and sutherlandiosides B and D profiles and peak area values. In the case of 
sutherlandiosides B and D, a standard curve of concentration versus the peak area was 
set-up, analyzed by linear regression and used to quantify the levels of sutherlandiosides 
B and D in all the plant samples.  
 
4.4 iBatech
TM
 experiment 
Sutherlandia frutescens plants grown under shade-house conditions were maintained 
under these conditions for the duration of the experiment and watered at the nursery 
manager’s discretion, as prior to the experiment. The plants were divided into three 
groups of five plants each i.e. group-A control; group-B 50% treatment group and group-
C) 100% treatment group. The control group had no treatment and was kept in the same 
location as other groups to minimise environmental variations. The iBatech
TM
 product 
was diluted according to the manufacturers specifications i.e. 100 ml of product diluted 
into one litre of water, used as the 100% treatment concentration and 50 ml diluted into 
one litre of water, as the 50% treatment concentration. The product dilutions were applied 
to the plant leaf and stem surface, using a standard 500 ml plant spray bottle. During 
iBatech
TM
 product applications, the plants were moved to a well-ventilated area to 
prevent product mist residues from coming into contact with the other plant groups. The 
plants were treated with the iBatech
TM
 product once per week and harvested after 30 days 
of treatment (with a total number of four treatments). The leaves and stems from each 
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individual plant, of three plants of each experimental group were taken as an individual 
sample, resulting in nine samples. These nine samples were dried and stored in the same 
manner as previously described in section 4.2.  
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Figure 4.2: Plant sample collection for the iBatech
TM
 experiment 
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4.5 Confirmation of the identified peaks, using Liquid Chromatography – Mass 
Spectrometry 
Fractions of the sutherlandiosides B and D were collected and pooled together, then 
subjected to liquid chromatography - mass spectrometric (LC-MS) analysis to confirm 
their identity. The LC-MS was performed at Stellenbosch University, Central Analytical 
Facility, on a Waters API Q-TOF Ultima LC-MS instrument. The sample was diluted 10 
times with 1 ml 0.1% formic acid and 50% acetonitrile using an ultrasonic bath for 20 
minutes then a 2 µL injection volume was injected onto the column (Waters BEH C18, 
2.1x50 mm). The mobile phase consisted of solvent A: water and solvent B: acetonitrile, 
with a gradient of 0 minutes to 0.5 minutes solvent A was 100%, from 0.5 to 6 minutes 
solvent A decreased steadily to 0% from 6 minutes to 8 minutes, solvent B remained at 
100% at 8.01 minutes and the system was re-equilibrated to 100% of solvent A with a 
total run-time of 15 minutes and a flow rate of 0.35 ml /minute.  
 
The detection conditions were as follows: source ESI +, capillary voltage set at 3.5 kV, 
cone voltage 35, RF1 40, source temperature 100 °C, desolvation temperature 350 °C, 
desolvation gas flow 350 L/h and cone gas flow 50 L/h. The mass to charge ratio (m/z) of 
the LC-MS data was noted and compared to existing data in the literature to confirm the 
identity of the compounds.  
 
4.6 Identification and quantification of sutherlandiosides B and D. 
The sutherlandiosides B and D from the samples were identified based on retention times 
and spectral analysis, and compared to that obtained from a standard mixture of 
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sutherlandiosides B and D, isolated and purified by the University of Mississippi. The 
serial dilutions containing 0.465 mg /ml, 0.931 mg /ml, 1.862 mg /ml, 3.725 mg /ml, 7.45 
mg /ml, were injected in triplicate. Standard curves of the concentrations vs. peak area 
were obtained and used to quantify sutherlandiosides B and D in all plant samples, using 
linear regression and the Graphpad prism5 software. 
 
4.7 Statistical analysis 
The statistical analysis was performed using the GraphPad Prism 5 software at a 
significance level of 0.05, in the following manner. The Kruskal-Wallis test was used to 
determine if there were any significant differences in the mean levels of sutherlandins 3 
and 4 and sutherlandiosides B and D, among the experimental groups and was applied to 
both the environmental group data and iBatech
TM
 experiment data. Furthermore, groups 
that showed to be significantly different, was subjected to the post ANOVA, Dunn’s 
Multiple Comparison test. The Mann-Whitney, two-tail, t-test was used to compare the 
mean levels of each experimental group to the standard and was only applied to the 
environmental group data. Lastly, the column statistics was done to determine whether 
there were any significant differences among samples from the same group.   
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CHAPTER 5 
 
Results and discussion 
 
The results obtained in the location of the sites where Sutherlandia is grown, the 
determination of the profiles and the average peak areas of sutherlandins 3 and 4 and 
sutherlandiosides B and D, the effects of the iBatech
TM
 product treatment on the profiles 
and average peak areas of sutherlandins 3 and 4 and sutherlandiosides B and D, and the 
quantification of sutherlandiosides B and D, are presented and discussed here.  
 
5.1 Growth environments and locations in which Sutherlandia is grown in the 
Western Cape area used in this study 
To determine the growth environments in which Sutherlandia is grown in the Western 
Cape area, various sites were visited and analyzed for their relative collective growth 
conditions, broadly categorized into the 1. natural field, 2. cultivated field or 3. 
greenhouse environmental categories and allocated a site number which represents a 
specific location from which the plant material was collected and will be referred to from 
here forward. The weather conditions at the time of collection, the presence or absence of 
flowers and/ or seedpods and the height were documented and are presented in Table 5.1 
below. Site 5 and 6 samples were donated and therefore the variables are unknown.
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Table 5.1: The environmental category, sample name, weather conditions at time of collection, presence or absence of flowers 
or seedpods and height 
 
 
 
 
 
Environmental 
category 
Samples 
Conditions at 
collection 
Presence of 
flowers 
Presence of seed 
pods 
Height cm 
Natural field 
Site 1 Sunny/ windy No Yes 10-20 
Site 2 Cold/ snowy Yes No 10-20 
Site 3 Sunny Yes Yes 20-30 
Cultivated field 
Site 4 Sunny No No 40-60 
Site 5 
 
 Unknown 
 
 Unknown 
 
 Unknown 
 
 Unknown 
Site 6 
 
 Unknown 
 
 Unknown 
 
 Unknown 
 
 Unknown 
Greenhouse 
Site 7 Shady No No 40-60 
Site 8 Shady No No 30-40 
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From the range of weather conditions at the time of collection, the greenhouse category 
appears more uniform. As covered in the literature, environmental growth conditions play 
a fundamental role in the synthesis of secondary metabolites (Mosaleeyanon et. al., 
2005). The natural field category samples i.e. Site 1, Site 2, and Site 3, were collected 
from the Western Cape’s natural Fynbos locations. From the literature reviewed, the 
Western Cape Fynbos region should be experiencing the summer drought period, after 
the long wet winter (Aschmann, 1973). From the conditions at harvest column, it is 
evident that the weather patterns are not true to that described in the literature. The 
observations made here were only performed on the day of collection and therefore 
cannot be generalized for the season, however, these environmental factors, when 
experienced for a prolonged period, could affect the concentrations (Wink, 1999) of 
sutherlandins 3 and 4, and sutherlandiosides B and D.  
 
The presence and or absence of flowers and seedpods provide an indication as to which 
stage of development the plant may be in. Previous studies suggest that the stage of 
development also greatly affects the synthesis of secondary metabolites (Whisgary et. al., 
unpublished data), as it is believed that during the early stages of development the plant 
allocates assimilated carbon and nitrogen to primary growth (Bourgaud et. al., 2001) and 
once growth plateaus, assimilated carbon and nitrogen can be allocated to secondary 
growth and the synthesis of secondary metabolites. In the case of flowering, the plant has 
reached a secondary growth stage, however, assimilated carbon and nitrogen is now 
allocated to flowering and the development of seeds, thus reducing the concentrations of 
secondary metabolites. In the natural field flowers and seedpods are present and therefore 
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the plant is in the developmental stage to be able to produce secondary metabolites such 
as sutherlandins 3 and 4 and sutherlandiosides B and D. The fact that flowers and 
seedpods are present could also mean that the concentrations of these secondary 
metabolites could have been compromised at the time of collection and may be increased 
in the stages before and after flowering. The absence of flowers and seedpods in the 
greenhouse category can be attributed to the controlled environment under which these 
plants are grown (Zobayed et. al., 2004). In the natural field and cultivated field 
categories plants are exposed to natural seasonal cycles and therefore should be flowering 
as per normal, at the time of harvest (early spring) (Pienaar, 2001). The greenhouse 
category however, maintains fairly constant growth conditions throughout the year, 
regardless of season, thus the plant no longer follows its natural growth cycle.  
 
The two samples in the greenhouse category are both shady and this could explain for the 
height being greater than that of the other categories. When plants are in competition for 
light, they tend to invest more energy into longitudinal growth than latitudinal growth; 
however, plant biomass cannot necessarily be used as an indication for secondary 
metabolite concentrations. It is often observed, that smaller, more compact plants have 
higher secondary metabolite yields compared to that of taller plants. Overall, the 
greenhouse category shows more uniform characteristics whereas the natural field and 
cultivated field categories have considerably varying characteristics. 
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5.2 Determination of the profiles and peak areas of sutherlandins 3 and 4 and 
sutherlandiosides B and D of S. frutescens samples from the three environmental 
categories, the S. frutescens Afriplex
TM
 standard and the iBatech
TM 
treatment
 
The aim was to determine if there were any variations in the profiles and average peak 
area values of Su3, Su4, SuB and SuD in the plant samples collected from the natural 
field, cultivated field, greenhouse categories when compared to the S. frutescens 
Afriplex
TM
 standard sample, and to determine any variations in average peak area values 
among the iBatech
TM
 treatment groups, using HPLC.  
 
5.2.1 HPLC assay validation 
To validate the HPLC assay used for the analysis of Su3, Su4, SuB and SuD in the S. 
frutescens samples, inter-day variations, intra-day variations and the construction of 
calibration curves were used according to the ICH guidelines for analytical methods. In 
Figure 5.1 is a representative chromatogram of S. frutescens obtained from the analysis of 
the Afriplex
TM
 sample, which is being used in this study, as a standard to compare the 
natural field, cultivated field and greenhouse categories to. The fingerprint obtained, 
illustrates the presence of a number of metabolites however for this study only 
sutherlandins 3 and 4 (Su3 and Su4) and sutherlandiosides B and D (SuB and SuD) were 
monitored. For inter-day and intra-day analysis (Appendix Table 1), the S. frutescens 
Afriplex
TM
 standard plant material was used, whereas the isolated standard SuB/ SuD 
ratio was used to construct the calibration curves. 
 
 
 
 
 
  
48 
 
Figure 5.1: HPLC chromatographic fingerprint of S. frutescens Afriplex
TM
 sample 
used as plant sample standard 
 
The spectral data was obtained (Figure 5.2) and found to conform to those of flavonoids 
and terpenoids. The flavonoids Su3 and Su4, were compared to the spectral data obtained  
by Hess et. al., (unpublished data) with the relative retention times of 4.361 and 5.093 
respectively and the terpenoids SuB and SuD, were compared to the spectral data 
obtained by Avula et. al., (2010) with the relative retention times of 14.919 and 15.222 
respectively, to verify their identity. 
 
 
Figure 5.2: The spectral data for Su3, Su4, SuB and SuD 
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Serial dilutions of the sutherlandiosides B and D standard were prepared and a 10uL 
injection was made onto the HPLC column. The following chromatogram (Figure 5.3) is 
a representation of the SuB and SuD standard ratio and also provides the spectral data as 
well as the relative retention times. This was then used for accurate identification of 
sutherlandiosides B and D in all the plant samples analyzed with HPLC. 
 
 
Figure 5.3: Representative chromatogram of SuB and SuD standard ratio 
 
5.2.2 Profiles and average peak area values of sutherlandins 3 and 4 and 
sutherlandiosides B and D of S. frutescens samples from the Afriplex
TM
 standard, 
natural field, cultivated field and greenhouse environmental categories 
The aim was to determine the qualitative variations, if any, in the profiles of 
sutherlandins 3 and 4 and sutherlandiosides B and D. The following chromatograms serve 
as representatives for all of the samples analyzed from the same environmental category. 
The samples collected from the various sites and categorized into the environmental 
categories, were allocated a name with the relative environmental category in brackets 
e.g. Site 1 (NF), and will be referred to from here forth. One gram of representative plant 
sample from each site was extracted with 10 ml MeOH. A 10 µL sample was injected to 
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obtain the chromatograms as described in method 4.3. Sutherlandin 3 (Su3), sutherlandin 
4 (Su4), sutherlandioside B (SuB) and sutherlandioside D (SuD) were monitored. 
 
Figure 5.4 represents the natural field (NF) group. Sutherlandins 3 and 4 quantities are 
minimal in the Site 1 (NF) sample and considerably increased in the Site 2 (NF) and Site 
3 (NF) samples. In Site 2 (NF) sutherlandin 3 is greater than 4 and vice versa in the Site 3 
(NF) sample. Sutherlandiosides B and D are also in greater quantity in the Site 3 (NF) 
sample and unidentifiable in the Site 1 (NF) and Site 2 (NF) samples. 
 
Figure 5.5 shows dramatic variations in the quantities of Su3, Su4, SuB and SuD among 
all samples. The Site 4 (CF) sample shows the lowest quantities whereas the Site 5 (CF) 
shows higher quantities and Site 6 (CF) dramatically higher quantities especially in SuB 
and SuD when compared to all other samples analyzed across all environmental 
categories. Figure 5.6 shows Su3, Su4, SuB and SuD profiles with no visible variations in 
quantities between the Site 7 (GH) and Site 8 (GH) samples. 
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a) 
 
 
b) 
 
 
 
 
 
  
52 
c) 
 
Figures 5.4 a , b and c: Representative HPLC chromatograms for the natural field 
category samples.  
 
a) 
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b) 
 
 
c) 
 
 
Figures 5.5 a, b and c: Representative HPLC chromatograms for the cultivated field 
category samples. 
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a) 
 
 
b) 
 
Figures 5.6 a and b: Representative HPLC chromatograms for the greenhouse 
category samples.  
 
Figures 5.7, 5.8, 5.9, and 5.10, represent the average peak area values of Su3, Su4, SuB 
and SuD respectively and compares the average peak area values for the natural field 
(NF), cultivated field (CF) and greenhouse (GH) environmental categories to that of the 
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Afriplex
TM
 S. frutescens plant material (Std.) used as the standard. The error bars plotted 
illustrate the standard deviation among three homogenized samples collected from the 
different sites but in the same environmental category.  Due to the unavailability of a 
third sample from the greenhouse category, the error bar represents the standard deviation 
of two samples.  
 
Figure 5.7:  Sutherlandin 3 (Su3)   Figure 5.8:  Sutherlandin 4 (Su4) 
 
 
Figure 5.9:  Sutherlandioside B (SuB) Figure 5.10:  Sutherlandioside D (SuD) 
 
Figure 5.7 (sutherlandin 3) illustrates the average peak area values of Su3 for the 
Afriplex
TM
 (Std.) 2495.08, the natural field (NF) 2810.33, the cultivated field (CF) 
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2519.81 and the greenhouse (GH) 2580.25 categories. Figure 5.8 (sutherlandin 4) 
illustrates the average peak area values of (Std.) 2065.18, (NF) 1495.67, (CF) 3114.42 
and (GH) 2361.72, with the CF group showing the highest average peak area values of 
Su4 and the NF showing the lowest. The GH group shows higher average peak area 
values of sutherlandin 4 than that of the Std. Figure 5.9 (sutherlandioside B) illustrates 
the average peak area values of (Std.) 236.95, (NF) 189.7, (CF) 594.56 and (GH) 326.72, 
however, the CF group shows the highest average peak area values for SuB. Figure 5.10 
(sutherlandioside D) illustrates the average peak area values of the (Std.) 255.38, (NF) 
144.1, (CF) 544.37 and (GH) 387.49 groups for SuD, with the NF category having the 
lowest average peak area values.  
 
The Kruskal-Wallis test was used to determine whether there are any statistically 
significant differences among the environmental categories, for sutherlandins 3 and 4 and 
sutherlandiosides B and D. The data for sutherlandin 4 (Su4) was significant (P = 
0.0021) and therefore the post ANOVA, Dunn’s Multiple Comparison test was performed 
to determine which groups were significantly different. The results showed that the 
natural field group was significantly different to both the cultivated field and greenhouse 
groups.  
 
The Mann-Whitney, two-tail, t-test was used to analyze the data for Su3, Su4, SuB and 
SuD, to compare each environmental category to the standard, however, no significant 
differences were found.  
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The column statistics of the raw data was analyzed to determine if there were any 
significant differences among samples from the same environmental category. 
Sutherlandin 3 (Figure 5.7), illustrated significant differences in Su3 concentrations 
among the samples from the same environmental category i.e. NF (P = 0.0005), CF (P = 
0.0001) and GH (P = 0.0001). Sutherlandin 4 (figure 5.8), illustrated significant 
differences in Su4 concentrations among samples when analyzing the NF (P = 0.0001), 
CF (P = 0.0001) and GH (P = 0.0001) groups. Sutherlandioside B (figure 5.9), illustrated 
significant differences in SuB concentrations for NF (P = 0.0189), CF (P = 0.0140) and 
GH (P = 0.0001) among samples from the same group. Sutherlandioside D (figure 5.10), 
had significant differences in SuD concentrations among samples for the NF (P = 
0.0192), CF (P = 0.0308) and GH (P = 0.0001) groups. 
 
In summary, the data shows that only sutherlandin 4 (Su4) was significantly different. 
The natural field group was significantly different to both the cultivated field and 
greenhouse groups. When comparing all groups to the standard, no significance was 
found, however, significant differences were found among samples from the same 
environmental group. These significant differences among samples from the same group 
can therefore be responsible for the lack of significant differences among environmental 
categories due to the wide range of data.  
 
 
 
 
 
 
  
58 
5.2.3 Profiles and average peak area values of sutherlandins 3 and 4 and 
sutherlandiosides B and D of S. frutescens samples from the iBatech
TM
 treatment 
experiment  
The chromatograms presented in Figure 5.11 illustrate minimal visual differences in Su3, 
Su4, SuB and SuD profiles when comparing the control group, 50% treatment group and 
100% treatment group. However, with closer examination of the average peak area 
values, a concentration dependant increase in Su3, Su4, SuB and SuD are evident. One 
gram of representative plant sample for each site was extracted with 10 ml MeOH. A 10 
µL sample was injected to obtain the chromatograms as described in method 4.3. 
Sutherlandin 3 (Su3), sutherlandin 4 (Su4), sutherlandioside B (SuB) and 
sutherlandioside D (SuD) were monitored. 
 
a) 
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b) 
 
c) 
 
 
Figures 5.11 a, b and c: Representative HPLC chromatograms for the iBatech
TM
 
samples.  
 
Figures 5.12, 5.13, 5.14 and 5.15 illustrate the average peak area values of Su3, Su4, SuB 
and SuD for the plants subjected to the iBatech
TM
 product treatment, with a control 0%, 
50% and 100% treatment concentrations. The error bars plotted represent three plant 
samples from the same product treatment concentration.  
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Figure 5.12: Sutherlandin 3 (Su3)  Figure 5.13: Sutherlandin 4 (Su4) 
 
 
Figure 5.14: Sutherlandioside B (SuB)  Figure 5.15: Sutherlandioside D (SuD) 
 
Figure 5.12 (sutherlandin 3) illustrates the average peak area values of the (control) 
9758.43, the (50%) 2232.63 and the (100%) 2031.97 treatment groups. Figure 5.13 
(sutherlandin 4) illustrates the average peak area values of the (control) 2241.63, the 
(50%) 2247.47 and the (100%) 2392.60 treatment groups, with the 100% treatment group 
having the highest average peak area values of Su4. Figure 5.14 (sutherlandioside B) 
illustrates the average peak area values of the (control) 289.66, the (50%) 284.93 and the 
(100%) 332.30 treatment groups. Figure 5.15 (sutherlandioside D) illustrates the average 
 
 
 
 
  
61 
peak area values of the (control) 282.77, the (50%) 280.60 and the (100%) 315.13 
treatment groups, with the 100% treatment group having the highest average peak area 
values for SuD. 
 
The Kruskal-Wallis test was used to determine whether there are any variations among 
the iBatech
TM
 experimental groups for sutherlandins 3 and 4 and sutherlandiosides B and 
D. The data for sutherlandioside B (SuB) was significant (P = 0.0390) and therefore the 
post ANOVA, Dunn’s Multiple Comparison test was performed to determine which 
groups were significantly different. The results showed that the 50% treatment group was 
significantly different to the 100% treatment group.  
 
The column statistics of the raw data was analyzed to determine if there were any 
significant differences among samples from the same iBatech
TM
 treatment group. 
Sutherlandin 3 (Figure 5.12) showed significant differences among samples from the 
50% (P = 0.0001) and 100% (P = 0.0001) treatment groups but not from the control (P = 
0.3158) group. Sutherlandin 4 (Figure 5.13) had significant differences among samples 
from the control (P = 0.0001), 50% (P = 0.0001) and 100% (P = 0.0001) treatment 
groups. Sutherlandioside B (Figure 5.14) had significant differences among the samples 
from the control (P = 0.0001), 50% (P = 0.0001) and 100% (P = 0.0001) treatment 
groups. Sutherlandioside D (Figure 5.15) had significant differences among the samples 
from the control, 50% and 100% treatment groups.  
 
 
 
 
 
  
62 
In summary, sutherlandioside B was found to have significant differences when 
comparing the 50% and 100% treatment groups. It is important to note that there were 
significant differences among all samples from all of the iBatech
TM
 treatment groups, 
except for sutherlandin 3 in the control group. This means that the data had a wide range 
and could explain why significant differences could not be found when comparing the 
different treatment groups.  
  
5.3 Liquid Chromatography – Mass Spectrometry  
HPLC was performed on Sutherlandia frutescens Afriplex
TM
 plant material as described 
in section 4.2 and fractions of the SuB and SuD collected and pooled. Due to the nature 
of sutherlandiosides B and D i.e. the compounds elute with less than a minute apart, 
which complicates collecting them as separate fractions. The pooled collected fractions 
were used for liquid chromatography – mass spectrometric (LC-MS) analysis. The 
standard SuB and SuD fraction obtained from the University of Mississippi was also a 
ratio between the two compounds. 
  
The fractions collected from the Sutherlandia frutescens Afriplex
TM
 sample with the 
spectral data conforming to those of sutherlandiosides B and D (SuB and SuD) as 
described by Avula et. al. (2010), were subjected to mass spectrometry for verification of 
their identities. The prominent compound in the collected fraction (Figure 5.16 and 
Figure 5.17) was eluted at retention time 7.23 minutes and had a mass of 635.4412. 
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SUB/D
Time
1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00
%
1
CS_Bioc_100817_07 TOF MS ES+ 
BPI
143
7.23;635.44
7.12;489.37
5.23
331.23
14.19
871.60
13.48
887.607.27;635.44
13.46;887.60
13.43;887.6011.61
885.59
11.50;885.597.46;816.54
11.45;885.59
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Figure 5.16: An LC-MS chromatogram of the collected SuB/ SuD pooled fraction 
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Figure 5.17: LC-MS mass spectral chromatogram for the collected SuB/ SuD fraction 
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Table 5.2: The concentrations of sutherlandiosides B and D in mg/ml in all plant samples 
 
 
 SuB                                          SuD 
Environmental 
category Sample Name  
Peak Area Concentration 
mg/ml 
Peak Area Concentration 
mg/ml 
Natural field 
category 
Site 1 53.566 0.15 43.066 0.09 
Site 2 67.233 0.19 48.100 0.11 
Site 3 448.300 1.43 341.133 1.15 
Cultivated field 
category 
Site 4 216.433 0.68 231.800 0.76 
Site 5 212.733 0.66 32.766 0.05 
Site 6 1354.500 4.36 1368.533 4.80 
Greenhouse 
category 
Site 7 275.500 0.87 321.900 1.08 
Site 8 377.933 1.20 453.066 1.55 
iBatech 
experiment 
iBatech 0% 
(control) 
289.666 0.91 282.766 0.94 
iBatech 50% 
treatment 
284.933 0.90 280.600 0.93 
iBatech 100% 
treatment 
332.300 1.05 315.133 1.06 
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5.4 Quantification: concentrations of sutherlandiosides B and D in samples collected 
from the natural field group, cultivated field group, greenhouse group and the 
iBatech
TM
 experiment  
In both the NF and CF groups (Table 5.2) there appears to be dramatic variations in the 
concentrations of SuB and SuD. The Site 3 (CF) and Site 6 (CF) samples have a five and 
six fold increase respectively in SuB and SuD concentrations when compared to the Site 
1 (NF), Site 2 (NF), Site 4 (CF) and Site 5 (CF) samples. The GH group also had 
differences among samples from the same group but appear relatively uniform when 
compared to the iBatech
TM
 control group and iBatech
TM
 50% treated group that were also 
grown in a greenhouse. The iBatech
TM 
100% treated group shows an increase in SuB and 
SuD concentrations to that of the iBatech
TM
 control and iBatech
TM
 50% treated groups.  
 
In conclusion, there were dramatic variations in the environmental factors of samples 
from the same environmental category; however the environmental factors in the 
greenhouse group, appeared more uniform. Significant differences were found in 
sutherlandin 4 when comparing the different environmental categories and 
sutherlandioside B when comparing the 50% and 100% treatment groups in the 
iBatech
TM
 experiment. Furthermore, significant differences were found in metabolite 
profiles and peak area values of Su3, Su4, SuB and SuD, among samples from the same 
environmental category as well as among samples from the iBatech
TM 
experiment. The 
LC-MS results obtained on the collected fractions confirm that it was SuB and SuD as 
described by Avula et. al. (2010) and the SuB and SuD quantification results suggest no 
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relationship between environmental category or iBatech
TM 
treatment group and the 
synthesis of these metabolites.    
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Chapter 6 
Conclusions and recommendations 
 
This study was aimed at to locate sites where S. frutescens is grown, broadly categorize 
the sites into environmental groups based on the pertinent environmental growth factors, 
to develop and validate a high-performance liquid chromatography method for Su3, Su4, 
SuB and SuD analysis, to determine and compare the profiles and levels of Su3, Su4, 
SuB and SuD S. frutescens grown in  different environmental growth sites and to 
determine whether the application of the iBatech
TM
 product increases the number and 
concentrations of secondary metabolites in S. frutescens. To achieve the aim of this study, 
a minimum of three S. frutescens samples (homogenized) per site, were collected from 
eight different sites and broadly categorized into three environmental categories viz. 1. 
natural field, 2. cultivated field and 3. greenhouse. S. frutescens plants were also grown in 
a greenhouse and treated with the iBatech
TM
 product, with a 0% control, 50% product 
concentration and 100% product concentration. A high performance liquid 
chromatography (HPLC) method was developed and validated, using the ICH guidelines, 
for the simultaneous analysis of flavonoids and terpenoids in S. frutescens and used for 
the profiling and determination of the average peak area values of sutherlandins 3 and 4 
and sutherlandiosides B and D. Liquid chromatography – mass spectrometry (LC-MS) 
was used to confirm the identity of the isolated and collected SuB and SuD pooled 
fractions. Furthermore, HPLC was also used for the construction of calibration curves, for 
the quantification of sutherlandiosides B and D (SuB and SuD) in all samples.  
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The specific objectives were: to determine and describe sites where Sutherlandia 
frutescens is grown, which could be broadly categorized into, 1. natural field, 2. 
cultivated field and 3. greenhouse and the pertinent growth factors which we assume 
could affect secondary metabolite synthesis, to determine sutherlandins 3 and 4 (Su3 and 
Su4) and sutherlandiosides B and D (SuB and SuD) profiles and average peak area values 
in S. frutescens collected from the eight sites, to determine the effects of the iBatech
TM
 
product treatment on sutherlandins 3 and 4 sutherlandiosides B and D profiles and 
average peak area values, and finally, to quantify the concentrations of sutherlandiosides 
B and D in all samples. 
 
From the results obtained in this study the following conclusions can be drawn: 
 
1. The sites that were categorized into three environmental categories illustrate a range of 
conditions at the time of collection, possible secondary metabolite synthesis-limiting 
factors and variations in plant size. The Su3, Su4, SuB and SuD profiles, average peak 
area values and concentrations of SuB and SuD can therefore not be correlated with the 
environmental categories. 
 
2. The sutherlandins 3 and 4 and sutherlandiosides B and D profiles and average peak 
area values vary among the different environmental growth categories. Variations in the 
profiles and peak area values are also visible among sites from the same environmental 
growth category. These variations can be attributed to the specific prevailing 
environmental conditions (micro-climates) at each site. The greenhouse (GH) group, 
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although not having significantly different, or the highest values for average peak areas of 
sutherlandins 3 and 4 and sutherlandiosides B and D, appear more uniform in the 
synthesis of these metabolites and can be attributed to the control of the environmental 
growth factors, which is the nature of a greenhouse.  
 
3. The iBatech
TM
 product appears to have had a concentration related effect; however 
these differences were not significant. To date, the iBatech
TM
 product has not been 
thoroughly investigated, thus its mechanism of action is unknown. Mass spectrometry 
results on the iBatech
TM
 product performed by the manufacturers reveal that although 
containing a wide variety of flavonoids and terpenoids it does not contain the specific 
compounds evaluated in this study. However, some of the compounds revealed by mass 
spectrometric analysis are known to act as precursor compounds. It is therefore plausible 
to deduce that in this experiment, these compounds acted as precursors and promoted the 
synthesis of sutherlandins 3 and 4 and sutherlandiosides B and D.  
 
4. The results obtained from the sutherlandiosides B and D (SuB and SuD) quantification, 
show two samples from the natural field (NF) and the cultivated field (CF) groups each 
with higher concentrations of SuB and SuD, when compared to the other samples. The 
greenhouse (GH), iBatech
TM
 control and iBatech
TM
 50% treatment groups, which were all 
grown under greenhouse environmental conditions, show more stable synthesis of SuB 
and SuD.  
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From these results, we can conclude that the greenhouse growth environment, although 
not producing the significantly highest concentrations of sutherlandins 3 and 4 and 
sutherlandiosides B and D, have more consistent/ uniform results with regard to 
environmental factors, metabolite profiles, average peak area values and the 
concentrations of sutherlandiosides B and D. I therefore recommend that S. frutescens 
grown for medicinal purposes, for the yield of sutherlandins 3 and 4 and 
sutherlandiosides B and D, be grown under greenhouse conditions in conjunction with the 
application of the iBatech
TM
 product to produce consistent concentrations of Su3, Su4, 
SuB and SuD. As we have covered in the literature review, the environmental growth 
factors can be controlled in the greenhouse. It would therefore be beneficial to more 
closely investigate the environmental conditions in the sites from the natural field (NF) 
and cultivated field (CF) groups, which show the highest concentrations of sutherlandins 
3 and 4 and sutherlandiosides B and D, and mimic those conditions in the greenhouse.    
 
The results of this study are important in understanding the best suited environmental 
growth factors, applied collectively, in which to grow S. frutescens for greater yields of 
sutherlandins 3 and 4 and sutherlandiosides B and D, when growing S. frutescens for 
medicinal purposes.  
 
 
 
 
 
 
 
 
  
72 
Reference List 
 
Abdallah, R.M., Ghazy, N.M., Asaad, A,M., El-Sebakhy, N.A., Pirillo. A., Verotta. 
L., 1994. Pharmazie 48, 452-454.   
 
Adam, K.P., Thiel, R., Zapp, J., 1999. Incorporation of 1-(1-13C)-deoxy-D-xylulose in 
chamomile sesquiterpenes. Archives of Biochemistry 369, 127-132. 
 
Agenbag, L., 2006. A study on an altitude gradient investigating the potential effects of 
climate change on fynbos and the fynbos-succulent karoo boundary. M.Sc. thesis, 
Stellenbosch University, Stellenbosch.   
 
Ainsworth, C., 2006. Flowering and its manipulation. Annual Plant Reviews, volume 20. 
Blackwell Publishing Ltd. ISBN -10:1-4051-2808-9.  
 
Andrew, P.J.; Myer, B. 1999. Enzymatic function of nitric oxide synthesis. 
Cardiovascular Research 43 (3): 521–531.  
 
Arronne, G., de Micco, V., 2001. Seasonal dimorphism in the Mediterranean Cistus 
incanus L. subsp. incanus. Annals of Botany 87: 789-794. 
 
Aschmann, H., 1973. Distribution and peculiarity of Mediterranean ecosystems. 
Mediterranean Type Ecosystems: Origin and Structure (eds F.D. Castri 7 H.A. Mooney), 
pp. 11-20. Springer-Verlag, Berlin.  
 
Avula, B., Joshi, V.C., Wang, Y-H., Smillie, T.J., Fu, X., Li, X.C., Mabusela, W., 
Syce. J., Johnson, Q., Folk, W., Khan, I.A., 2010. Quantitative determination of 
flavonoids and cycloartane glycosides from the leaves and stems of Sutherlandia 
frutescens (L.) R. BR. By LC-UV/ELSD methods, confirmation by LC-MS and micro-
morphology studies. Journal of pharmaceutical and biomedical analysis 52 (2):173-80. 
 
 
 
 
  
73 
 
Banno, N., Akihisa, T., Tokuda, H., Yasukawa, K., Higashihara, H., Ukiya, M., et. 
al., 2004. Triterpene acids from the leaves of Perilla frutescens and their anti-
inflammatory and antitumor-promoting effects. Bioscience, Biotechnology and 
Biochemistry 68, 85-90.  
 
Baber, N. International Conference on Harmonization, 1994. Text on validation on 
analytical procedures – ICH Harmonized Guidline. 
 
Bates, S.H., Jones, R.B., Bailey, C. J., 2000. Insulin-like effect of pinitol. British 
Journal of Pharmacology 130, 1944-1948. 
 
Bell, E.A., 1958. Canavanine and related compounds in the Leguminosae. Biochemistry 
Journal 70, 617-619. 
 
Bourgaud, F., Gravot, A., Milesi, S., Gontier, E., 2001. Production of plant secondary 
metabolites: a historical perspective. Plant Science. 161, 839-851. 
 
Brekhman, I.I., Dardymov, I.V., 1969. New substances of plant origin which increase 
non-specific resistance. Annual Review of Pharmacology 9, 419-430. 
 
Brümmerhoff, S.W.D., 1969. Some constituents of Sutherlandia microphylla. D.Sc. 
Thesis. The University of the Free State, Bloemfontein. 
 
Buckingham, J., 2004. Dictionary of Natural Products 253-260. Chapman and 
Hall/CRC Press, London, New York. 
 
Calis, I., Yuruker, A., Tasdemir, D., Wright, A.D., Sticher, O., Luo, Y-D., Pezzuto, 
J.M., 1997. Cycloartane triterpene glycosides from the roots of Astragalus 
melanophrurius. Planta Medica 63 183-186. 
 
 
 
 
 
  
74 
Chapouthier, G, Venault P. 2001. A pharmacological link between epilepsy and 
anxiety? Trends in Pharmacological Sciences 22 (10) 491-493. 
 
Chinkwo, K.A., 2005. Sutherlandia frutescens extracts can induce apoptosis in cultured 
carcinoma cells. Journal of Ethnopharmacology 98, 163-170. 
 
Cowling, R.M., Rundel, P.W., Lamont, B.B., Arroyo, M.K., Arianoutsou, M., 1996. 
Plant diversity in Mediterranean-climate regions. Trends in Ecology and Evolution 11, 
362-366. 
 
Cowling, R.M., Ojeda, F., Lamont, B.B.,  Rundel, P.W., Lechmere-Oertel, R., 2005. 
Rainfall reliability, a neglected factor in explaining convergence and divergence of plant 
traits in fire-prone Mediterranean-climate ecosystems. Global Ecology and Biogeography 
14, 509-519.  
 
Crowell, P.L., 1999. Prevention and therapy of cancer by dietary monoterpenes. Journal 
of Nutrition 129, 775S-778S. 
 
Crozier, A., Clifford, M.N., Ashihara, H., 2006. Plant Secondary Metabolites. 
Occurrence, Structure and Role in the Human Diet. Blackwell Publishing. ISBN 1-4051-
2509-8. 
Dharmananda, S. 2000. Platycodon and Other Chinese Herbs with Triterpene 
Glycosides, Portland, Oregon, Institute for Traditional Medicine. 
Dini, I., Tenore, G.C., Dini, A., 2009. Saponins in Ipomoea batatas tubers: Isolation, 
characterization, quantification and anti-oxidant properties. Food Chemistry 113, 411-
419. 
 
Eisenreich, W., Menhard, B., Hylands, P.J., Zenk, M.H., Bacher, A., 1996. Studies on 
the biosynthesis of taxol: the taxane carbon skeleton is not of mevalonoid origin. 
 
 
 
 
  
75 
Proceedings of the National Academy of Sciences of the United States of America 93, 
6431-6436. 
 
Eisenreich, W., Sagner, S., Zenk, M.H., Bacher, A., 1997. Monoterpenoid essential 
oils are not of mevalonoid origin. Tetrahedron Letters 38, 3889-3892. 
 
Ercoli, L., Lulli, L., Mariotti, M., Masoni, A., Arduini, I., 2007. Post-anthesis dry 
matter and nitrogen dynamics in durum wheat as affected by nitrogen supply and soil 
water availability. European Journal of Agronomy 28, 138-147.  
 
Fernandes, A.C., Cromarty, A.D., Albrecht, C., Jansen Van Rensburg, C.E., 2004. 
The antioxidant potential of Sutherlandia frutescens. Journal of Ethnopharmacoloy 95, 1-
5. 
 
Folkman, J., 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. 
Nature Medicine 1, 27-31. 
 
Fraser, P.D., Bramley, P.M., 2004. The biosynthesis and nutritional uses of carotenoids. 
Progress in Lipid Research 43, 228-265. 
 
Foster AC, Kemp JA. 2006. Glutamate- and GABA-based CNS therapeutics. Current 
Opinions in Pharmacology 6 (1): 7–17.  
 
Fu, X., Li, X.-C, Smillie, T.J., Carvalho, P., Mabusela, W., Syce, J., Johnson, Q., 
Folk, W., Avery, M.A., Khan, I.A., 2008. Cycloartane glycosides from Sutherlandia 
frutescens. Journal of Natural Products 71, 1749-1753.  
 
Gabrielse, V.S., 1996. Pharmacological studies on rooperol, rooperol derivatives and 
Sutherlandia extracts. M.Sc. Thesis, University of Stellenbosch. 
 
 
 
 
 
  
76 
Gao, J., Liu, X., Rigas, B., 2005. Nitric oxide donating aspirin induces apoptosis in 
human colon cancer cells through induction of oxidative stress. Proceedings of the 
National Academy of Sciences of the United States of America 102, 17207-17212. 
Gaube, F., Wolfl, S.,  Pusch, L., Kroll, T.C., and Hamburger, M., 2007. Chemical 
structure of Actein, the major cycloartane-type triterpene glycoside of black cohosh. 
BMC Pharmacology 7:11. 
Green, M.H., 1998.  Methods of treating viral infections with amino-acid analogs. 
United States Patent 5,110,600. 
 
Haefele, S.M., Jabbar, S.M.A., Siopongco, J.D.L.C., Tirol-Padre, A., Amarante, 
S.T., Sta Cruz, P.C., Cosico, W.C., 2008. Nitrogen use efficiency in selected rice 
(Oryza sativa L.) genotypes under different water regimes and nitrogen levels. Field 
Crops Research 107, 137-146.  
 
Heng, L., Vincken, J-P., Hoppe, K., van Koningsveld, G.A., Decroos, K., Gruppen, 
H., van Boekel, M.A.J.S., Voragen, A.G.J., 2005. Stability of pea DDMP saponin and 
the mechanism of its decomposition. Food Chemistry 99, Issue 2, 326-33. 
 
Hess, M.S., Syce, J.A., Correlation between the antioxidant activities and total flavinoid 
levels of selected Sutherlandia products. MSc, thesis, University of the Western Cape, 
unpublished data. 
 
International Conference on Harmonization, 1996. Q2B Validation of analytical 
procedures: methodology - ICH Harmonized Tripartate Guidline. 
 
Janick, J., 1972. Horticultural Science, Second Edition. ISBN 0-7167-0823-3. 
 
Johnson, Q., Syce, J., Nell, H., Rudeen, K., Folk, W.R., 2007. A randomized, double-
blind, placebo-controlled trial of Lessertia frutescens in healthy adults. The Public 
Library of Science Clinical Trials 2 (4), art. no. e16. 
 
 
 
 
  
77 
 
Kashiwada, Y., Wang, H.K., Nagao, T., Kitanaka, S., Yasuda, I., Fujioka, T., et. al, 
1998. Anti-AIDS agents 30 Anti-HIV activity of oleanolic acid, pomolic acid, and 
structurally related triterpenoids. Journal of Natural Products 61, 1090-1095. 
 
Klaasen, J., Vries, F.A., 2009. Ethanol plant extracts and fungicidal mixtures with 
synergistic-type action. Patent reference no. PA149863/P. 
 
Lasztity, R., Hidvegi, M., Bata, A., 1998. Saponins in food, Food Review International 
14, 371-390. 
 
Lee, H.Y., Chung, H.Y., Kim, K.H., Lee, J.J., Kim, K.W., 1994. Differentiation in the 
cultured F9 teratocarcinoma stem cells by triterpene acids. Journal of Cancer Research in 
Clinical Oncology 120, 513-518. 
 
Lee, I., Lee, J., Lee, Y.H., Leonard, J., 2001. Ursolic acid-induced changes in tumor 
growth, O2 consumption, and tumor interstitial fluid pressure. Anticancer Research 21, 
2827-2834. 
 
Lichenthaler, H.K., 1999. The 1-deoxy-D-xylulose 5-phosphate pathway of isoprenoid 
biosynthesis in plants. Annual Reviews in Plant Physiology and Plant Molecular Biology 
50, 47-65.  
 
Lichtenthaler, H.K., Schwender, J., Disch, A., Rohmer, M., 1997. Biosynthesis of 
isoprenoids in higher plant chloroplasts proceeds via a mevalonate-independent pathway. 
Federation of European Biochemical Societies Letters 400, 271-274.  
 
Liu, J., 1995. Pharmacology of oleonolic acid and ursolic acid. Journal of 
Ethnopharmacology 49, 57-68. 
 
 
 
 
 
  
78 
Lovett, J.C., Midgley, G.F., Barnard, P., 2005. Climate change and ecology in Africa. 
African Journal of Ecology 43, 167-169. 
 
Manners, G.D., Hasegawa, S., 1999. Squeezing more from citrus fruits. Chemistry and 
Industry 542-545. 
 
McCarthy, J.J., Canziani, O.F., Leary, N.A., Dokken, D.J., White, K.S., 2001. 
Climate Change 2001: Impacts, Adaptations and Vulnerability. Intergovernmental Panel 
on Climate Change, Cambridge University Press, Cambridge (9) 451-485.  
 
Medicines Control Council of South Africa, Validation, GMP Compliance and 
Regulatory Consultants. PharmOut Pty. Ltd. www.pharmout.co.za. Accessed: 31 August 
2011. 
 
Medical Research Council and National Research Foundation of South Africa, 2002. 
A toxicity study of Sutherlandia leaf powder (Sutherlandia microphylla) consumption. 
Final  Report 2002. 
 
Mooney, H.A., Dunn, E.L., 1970. Convergent evolution of Mediterranean-climate 
evergreen sclerophyll shrubs. Evolution 24, 292-303. 
 
Mosaleeyanon, K., Zobayed, S.M.A., Afreen, F., Kozai, T., 2005. Relationships 
between net photosynthetic rate and secondary metabolite contents in St. John’s Wort. 
Plant Science 169, 523-531. 
 
Moshe, D., 1998. A biosystematic study of the genus Sutherlandia R.Br. (Fabaceae, 
Galageae). M.Sc. Thesis (Botany). University of Johannesburg.  
 
Moshe, D., Van Der Bank, H., Van Der Bank, M., van Wyk, B-E., 1998. Lack of 
genetic differentiation between 19 populations from seven taxa of Sutherlandia Tribe: 
Galageae, Fabaceae. Biochemical Systematics and Ecology 26, 595-609. 
 
 
 
 
  
79 
 
Ojewole, J.A.O., 2004. Analgesic, anti-inflammatory and hypoglycemic effects of 
Sutherlandia frutescens R.Br. (variety incana E. Mey.) (Fabaceae) shoot aqueous extract. 
Methods and Findings in Experimental and Clinical Pharmacology 26, 409-416.  
 
Olivier, D.K., Albrecht, C.F., van Wyk, B-E., van Heerden, F.R., 2009. SU3, an 
oxocycloartane diglycoside from Sutherlandia humulis. Phytochemistry Letters 2, 123-
125. 
 
Passam, H.C., Polissiou, M.G., Daferera, D., Petropoulos, S.A., 2007. The effect of 
water deficit stress on the growth, yield and composition of essential oils of parsley. 
Scientia Horticulturae 115, 393-397. 
 
Pandian, S., Saengchjan, S., Raman, T.S., 1981. An alternative pathway for the 
biosynthesis of isoprenoid compounds in bacteria. Biochemical Journal 196, 675-681. 
Phillips, R., Dyer, R.A., 1934. The genus Sutherlandia R. Br. Revista Sudamericana de 
Botánica I 69-90. 
Piel, J., Donath, J., Bandemer, K., Boland, W., 1998. Mevalonate-independent 
biosynthesis of terpenoid volatiles in plants: induced and constitutive emission of 
volatiles. Angewandte Chemie International Edition 37, 2478-2481.  
 
Pienaar, K. 2001. The South African what flower is that? ISBN: 1-86872-588-X. 
 
Price, K.R., Griffiths, N.M., Curl, C.L., Fenwick, G.R., 1985. Undesirable sensory 
properties of the dried pea (Pisum sativum). The role of saponins., Food Chemistry 17 
105-115. 
 
Rassaa, N., Salah, H.B.H., Latiri, K., 2008. Thermal responses of Durum wheat 
Triticum durum to early water stress. Consequence on leaf and flower development. C.R. 
Biologies 331 (5) 363-371. 
 
 
 
 
  
80 
 
Schwender, J., Seeman, M., Lichenthaler, H.K., Rohmer, M., 1996. Biosynthesis of 
isoprenoids (carotenoids, sterols, prenyl side-chains of chlorophylls and plastoquinone) 
via a novel pyruvate/glyceraldehyde 3-phosphate non-mevalonate pathway in the green 
alga Scenedesmus obliquus. Biochemical Journal 316, 73-80. 
 
Shah, S.P.J., Rogers, L.J., 1969. Compartmentation of terpenoid biosynthesis in green 
plants. Biochemical Journal 114, 395-405.  
 
Sia, C., 2004. Spoghtlight on ethnomedicine: usability of Sutherlandia frutescens in the 
treatment of diabetes. The Review of Diabetic Studies 1, 145-149. 
 
Simões, M., Simões, L.C., Cleto, S., Machado, I., Pereira, M.O., Vieira, M.J., 2007. 
Antimicrobial mechanisms of ortho-phthalaldehyde action. Journal of basic 
Microbiology 47, 230-242. 
 
Smith, C., Myburgh, K.H, 2004. Treatment with Sutherlandia frutescens ssp. 
microphylla alters the corticosterone response to chronic intermittent immobilization 
stress in rats. South African Journal of Science 100, 229-232. 
 
Snyders, J.H., 1965. Chemical investigation of Sutherlandia microphylla Burch. M.Sc. 
Thesis. University of the Free State, Bloemfontein. 
 
Somova, L.O., Nadar, A., Rammanan, P., Shode, F.O., 2003. Cardiovascular, 
antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental 
hypertension. Phytomedicine 10, 115-121. 
 
Southwell, I.A., Bourke, A.C., 2001. Seasonal variation in hypericin content of 
Hypericum perforatum L. (St. John’s Wort). Phytochemistry 56, 437-441. 
 
Stechmiller, J.K., Childress, B., Cowan, L., 2005. Arginine supplementation and 
wound healing. Nutrition in Clinical Practice 20 (13): 52–61.  
 
 
 
 
  
81 
 
Swaffar, D.S, 1995. Combination therapy with 5-flourouracil and L-canavanine: in-vitro 
and in-vivo studies. Anticancer Drugs 6, 586-593. 
 
Tai, J., Cheung, S., Chan, E., Hasman, D., 2004. In vitro culture studies of 
Sutherlandia frutescens on human tumor cell lines. Journal of Ethnopharmacology 93, 9-
19. 
 
Takano, M,. Yumoyo, R., Murakami, T., 2006. Expression and function of efflux drug 
transporters in the intestine. Pharmacological Therapeutics 109, 137-161. 
 
Tian, Z., Yang, M., Huang, F., Li, K., Si, J., Shi, L., Chen, S., Xiao, P., 2005. 
Cytotoxicity of three cycloartane triterpenoids from Cimicifuga dahurica. Cancer Letters 
226, 65-75. 
 
van Breemen, R.B., Sun, Y., Li, W., Fitzloff, J.F. 2007. Liquid Chromatography-
Electrospray Tandem Mass Spectrometry of Terpenoid Lactones in Ginkgo biloba. 
Journal of Mass Spectrometry 40(3), 373-379. 
 
Van Wyk, B-E.,  Albrecht, C., 2008. A review of the taxonomy, ethnobotany, chemistry 
and pharmacology of Sutherlandia frutescens (Fabaceae). Journal of Ethnopharmacology 
119, 620-629. 
 
Van Wyk, B-E., Wink, M., 2004. Medicinal plants of the world. Briza publications, 
Pretoria. ISBN 1 875093 44 3. 
 
Van Wyk, B-E., Van Oudtshoorn, B., Gerick, N., 1997. Medicinal plants of South 
Africa (second improved impression, 2000). Briza Publications, Pretoria. ISBN 1 875093 
09 5. 
 
 
 
 
 
  
82 
Visen, P.K.S., Bindula, S., Patnaik, G.K., Agarwal, D.P., Dhawan, B.N., 1996. 
Protective activity of picroliv isolated from Picrorhiza kurrooa against ethanol toxicity in 
isolated rat hepatocytes. Indian Journal of Pharmacology 28 (2) 98-101. 
 
Werner, C., Correia, O., Beyschlag, W., 1999. Two different strategies in 
Mediterranean macchia plants to avoid photoinhibitory damage by excessive radiation 
levels during summer drought. Acta Oecologica 20, 15-23. 
 
Whisgary, D., Le Roux, M.R., Johnson, Q. Effects of drought on carbon and nitrogen 
metabolism in Sutherlandia frutescens (Fabaceae) seedlings. BSc. (Hons) thesis, 
unpublished data. University of the Western Cape, Bellville.  
 
Wink, M., 1999. Functions in plant secondary metabolites and their exploration in 
biotechnology. Sheffield Academic Press, England, United Kingdom, 188-273.  
 
Witte, M.B.; Barbul, A 2003. Arginine physiology and its implication for wound 
healing. Wound Repair and Regeneration 11 (6): 419–423.  
 
Xiao, L., Zhang, J., Yin, Y.F., Chen, C.L., Li, K., Chang, A., Sirois, P., 2008. 
Molecular diagnoses of HIV and relevant novel technologies in mutation analysis. 
Biotechnology Advances 26, 389-397. 
 
Zobayed, S.M.A., Saxena, P.K., 2004. Production of St. John’s Wort plants under 
controlled environment for maximizing biomass and secondary metabolites. In Vitro 
Cellular & Developmental Biology. Plant 40, 108-114. 
 
 
 
 
 
 
 
 
  
83 
Appendixes 
 
Appendix 1:  
Assay validation data: SuB std. curve linear regression 
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Appendix 2:  
Assay validation data: SuD std. curve linear regression 
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Appendix 3: The values for standard deviation, the averages and percentage RSD of the intra and inter-day variations for assay 
validation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Su3 Su4 SuB SuD 
Intra-day STDeviation 46.56798 21.30078 5.345789 6.5292 
 Average 3220.178 1981.207 402.6148 427.3259 
 %RSD 1.44 1.07 1.32 1.52 
      
  Su3 Su4 SuB SuD 
Inter-day STDeviation 48.15179 22.38726 9.00924 35.61073 
 Average 3250.373 1991.1 426.0444 406.2852 
 %RSD 1.48   2.11 8.76 
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Appendix 4: Retention time and peak area averages and standard deviation values for Sites 1-8 and iBatech
TM 
experiment.  
Plant Samples 
sutherlandin 3 sutherlandin 4 sutherlandioside B sutherlandioside D 
Rt (mins) Area (mAU) Rt (mins) Area  (mAU) Rt (mins) Area  (mAU) Rt (mins) Area  (mAU) 
N
at
u
ra
l f
ie
ld
 Site 1 
4.355 ± 
0.014 
1527.9 ± 6.286 
5.115 ± 
0.013 
2045.03 ± 6.785 
15.005 ± 
0.005 
53.567 ± 
0.251 
15.341 ± 
0.003 
43.067 ± 
0.450 
Site 2 
4.312 ± 
0.128 
2330.17 ± 
1314.352 
5.1567 ± 
0.009 
907.867 ± 6.092 
15.326 ± 
0.003 
67.23 ± 2.112 
15.533 ± 
0.003 
48.1 ± 0.7 
Site 3 
4.338 ± 
0.013 
4572.93 ± 2.055 
5.098 ± 
0.016 
1534.1 ± 2.951 
14.329 ± 
0.020 
448.3 ± 2.271 
14.692 ± 
0.019 
341.133 ± 
2.490 
C
u
lt
iv
at
e
d
 f
ie
ld
 
Site 4 
4.417 ± 
0.025 
2444.5 ± 23.612 
5.3777 ± 
0.027 
1876.5 ± 16.802 
14.357 ± 
0.027 
216.433 ± 
2.350 
14.725 ± 
0.027 
231.8 ± 1.824 
Site 5 
4.49 ± 
0.019 
1747.27 ± 29.286 
5.254 ± 
0.126 
3433 ± 847.971 
14.944 ± 
0.027 
212.733 ± 
2.335 
15.299 ± 
0.023 
32.767 ± 
0.230 
Site 6 
4.430 ± 
0.036 
3367.67 ± 
1360.339 
5.377 ± 
0.017 
4033.77 ± 5.834 
14.756 ± 
0.027 
1354.5 ± 
2.497 
15.262 ± 
0.026 
1368.53 ± 
2.948 
G
re
e
n
-
h
o
u
se
 Site 7 
4.407 ± 
0.008 
2826.2 ± 3.716 
5.369 ± 
0.011 
2390.43 ± 0.550 
14.364 ± 
0.034 
275.5 ± 6.337 
14.731 ± 
0.034 
321.9 ± 3.704 
Site 8 
4.406 ± 
0.004 
2334.3 ± 3.831 
5.363 ± 
0.001 
2333 ± 2.951 
14.350 ± 
0.006 
377.933 ± 
5.481 
14.721 ± 
0.007 
453.067 ± 
3.444 
iB
at
ec
h
 
e
xp
e
ri
m
e
n
t 
iBatech 
0% 
4.463 ± 
0.017 
9758.433 ± 
12738.012 
5.3555 ± 
0.021 
2241.633 ±  
29.885 
15.525 ± 
0.009 
289.667 ± 
3.008 
15.880 ± 
0.008 
282.767 ± 
2.843 
iBatech 
50% 
4.45 ± 
0.010 
2232.633 ± 
22.292 
5.346 ± 
0.009 
2247.467 ± 
21.096 
15.518 ± 
0.007 
284.933 ± 
2.150 
15.873± 
0.008 
280.6 ± 2.151 
iBatech 
100% 
4.406 ± 
0.011 
2031.967 ± 
12.859 
5.364 ± 
0.005 
2392.6 ± 15.561 
15.521 ± 
0.010 
332.3 ± 0.624 
15.875 ± 
0.010 
315.133 ± 
2.676 
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Appendix 5: Unprocessed HPLC data for the iBatech
TM
 experiment and Sites 1-8.  
SAMPLE sutherlandin 3 sutherlandin 4 sutherlandioside B sutherlandioside D 
  Rt Area Height Width Rt Area Height Width Rt Area 
Heig
ht Width Rt Area 
Heig
ht Width 
iBatech 
Control 4.453 2426.9 283.5 0.1179 5.343 2250.2 387.8 0.0857 15.52 291.6 30.6 0.1332 15.875 285.1 35.8 0.117 
iBatech 
Control 4.452 2381.4 278.5 0.1198 5.344 2208.4 378.3 0.0861 15.519 286.2 29.9 0.1338 15.874 279.6 35.1 0.117 
iBatech 
Control 4.483 24467 286.4 0.1177 5.38 2266.3 390.6 0.0857 15.536 291.2 30.7 0.1328 15.89 283.6 35.8 0.1164 
iBatech 
50% 4.459 2258.3 391.7 0.0877 5.354 2271.7 391.7 0.0877 15.514 287.1 31.2 0.1295 15.868 282.7 33.4 0.1207 
iBatech 
50% 4.452 2221.5 239.4 0.1262 5.348 2237.5 392.2 0.0846 15.527 284.9 30.7 0.1322 15.882 280.7 32.9 0.1236 
iBatech 
50% 4.439 2218.1 239.7 0.1239 5.336 2233.2 388.4 0.0871 15.513 282.8 30.5 0.13 15.868 278.4 32.8 0.1232 
iBatech 
100% 4.414 2019.4 215 0.1256 5.369 2377.4 425.7 0.0852 15.517 332.1 34.2 0.1353 15.869 318.1 37.2 0.1237 
iBatech 
100% 4.412 2031.4 217.5 0.127 5.366 2391.9 425.6 0.0856 15.513 331.8 34.1 0.1355 15.868 312.9 37.2 0.1221 
iBatech 
100% 4.394 2045.1 213.6 0.1297 5.358 2408.5 425.6 0.086 15.532 333 34.5 0.1346 15.887 314.4 37.3 0.1202 
                                  
SAMPLE sutherlandin 3 sutherlandin 4 sutherlandioside B sutherlandioside D 
  Rt Area Height Width Rt Area Height Width Rt Area 
Heig
ht Width Rt Area 
Heig
ht Width 
NA 4.365 1529.1 154.2 0.1357 5.125 2048.8 263.1 0.1109 15.01 53.6 5.4 0.1418 15.344 43.5 6.1 0.1094 
NA 4.338 1521.1 153 0.138 5.099 2037.2 261.9 0.1107 14.999 53.3 5.3 0.1455 15.337 42.6 5.9 0.1116 
NA 4.362 1533.5 154.2 0.136 5.12 2049.1 265.4 0.1101 15.007 53.8 5.4 0.1426 15.343 43.1 6 0.1116 
NB 4.376 3072.7 310.2 0.1376 5.148 900.9 103.3 0.1218 15.328 68.3 5 0.1904 15.535 48.1 8.2 0.0928 
NB 4.395 3105.2 314 0.1374 5.167 910.5 106 0.1202 15.328 68.6 5 0.1887 15.536 48.8 8.3 0.0907 
NB 4.164 812.6 128.5 0.0938 5.155 912.2 105.5 0.1228 15.322 64.8 4.9 0.1834 15.529 47.4 8.2 0.0912 
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NC 4.324 4575.3 602.3 0.1086 5.082 1532.6 179.6 0.1356 14.306 447.3 67.7 0.0991 14.669 339.9 51.3 0.1014 
NC 4.351 4571.6 599.6 0.1089 5.114 1537.5 178.9 0.1382 14.342 450.9 67.9 0.0995 14.704 344 51.8 0.1015 
NC 4.338 4571.9 602.2 0.1086 5.099 1532.2 179.2 0.1378 14.34 446.7 68 0.1007 14.702 339.5 51.4 0.099 
                                  
SAMPLE sutherlandin 3 sutherlandin 4 sutherlandioside B sutherlandioside D 
  Rt Area Height Width Rt Area Height Width Rt Area 
Heig
ht Width Rt Area 
Heig
ht Width 
CA 4.404 2418.1 328.9 0.1038 5.365 1857.5 330.7 0.0855 14.334 216.4 28.3 0.1113 14.702 230.9 32.2 0.1076 
CA 4.401 2451.8 334.6 0.1035 5.359 1882.6 336.8 0.0832 14.349 214.1 28.3 0.1124 14.719 230.6 32.3 0.1073 
CA 4.446 2463.6 339.6 0.1026 5.409 1889.4 338.5 0.0851 14.387 218.8 28.7 0.113 14.755 233.9 32.6 0.1077 
CB 4.483 1754 265.6 0.097 5.189 3959.5 691.1 0.0868 14.96 213.2 27.5 0.1124 15.225 32.9 4.4 0.1065 
CB 4.475 1715.2 264.6 0.0956 5.173 3884.7 679.4 0.0867 14.912 210.2 27.3 0.112 15.208 32.5 4.4 0.1081 
CB 4.512 1772.6 271.8 0.0961 5.399 2454.8 434.5 0.0839 14.959 214.8 27.9 0.1119 15.254 32.9 4.5 0.1061 
CC 4.416 4146.6 426 0.1316 5.379 4027.6 666.3 0.0905 14.77 1352.5 
216.
5 0.0949 15.275 1365.2 
202.
4 0.1027 
CC 4.471 1796.9 400 0.0749 5.393 4034.5 676.7 0.0896 14.774 1357.3 
218.
2 0.0966 15.279 1369.6 
204.
1 0.1023 
CC 4.402 4159.5 423.5 0.1326 5.359 4039.2 666.8 0.0907 14.724 1353.7 
216.
8 0.0948 15.232 1370.8 202 0.1032 
                                  
SAMPLE sutherlandin 3 sutherlandin 4 sutherlandioside B sutherlandioside D 
  Rt Area Height Width Rt Area Height Width Rt Area 
Heig
ht Width Rt Area 
Heig
ht Width 
GA 4.416 2829.7 384.4 0.1059 5.382 2389.9 425 0.0856 14.404 268.2 37.7 0.1069 14.77 317.7 48.2 0.0989 
GA 4.406 2822.3 384.2 0.1037 5.364 2390.4 426.8 0.0853 14.341 279.6 38.7 0.1084 14.705 323.3 47.7 0.1031 
GA 4.4 2826.6 384 0.1039 5.362 2391 428.2 0.0851 14.348 278.7 37.9 0.1079 14.719 324.7 48.5 0.102 
GB 4.409 2331.7 331.6 0.102 5.362 2331.1 426.9 0.0817 14.345 371.7 47.9 0.1146 14.715 449.1 63 0.1071 
GB 4.407 2338.7 335.3 0.1014 5.363 2336.4 422.2 0.0846 14.357 380.1 48.4 0.1155 14.729 454.8 62.8 0.1085 
GB 4.401 2332.5 334.2 0.0994 5.364 2331.5 419.4 0.0849 14.347 382 48.4 0.1162 14.718 455.3 62.7 0.1087 
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